Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stem Cell Research

  Free Subscription

Articles published in
Bone Marrow Transplant
    September 2021
  1. PINCEZ T, Santiago R, Bittencourt H, Louis I, et al
    Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children.
    Bone Marrow Transplant. 2021 Sep 2. pii: 10.1038/s41409-021-01408.
    >> Share

    August 2021
  2. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    >> Share

  3. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    >> Share

  4. MALLADI R, Ahmed I, McIlroy G, Dignan FL, et al
    Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.
    Bone Marrow Transplant. 2021 Aug 26. pii: 10.1038/s41409-021-01439.
    >> Share

  5. XU LP, Lu PH, Wu DP, Sun ZM, et al
    Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01431.
    >> Share

  6. GOKLEMEZ S, Saligan LN, Pirsl F, Holtzman NG, et al
    Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01419.
    >> Share

  7. SNARSKI E, Stringer J, Mikulska M, Gil L, et al
    Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of
    Bone Marrow Transplant. 2021 Aug 21. pii: 10.1038/s41409-021-01430.
    >> Share

  8. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 20. pii: 10.1038/s41409-021-01437.
    >> Share

  9. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01425.
    >> Share

  10. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of H
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01404.
    >> Share

  11. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01405.
    >> Share

  12. GRANELL M, Senin A, Barata A, Cibeira MT, et al
    Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2021 Aug 17. pii: 10.1038/s41409-021-01429.
    >> Share

  13. JAYANI RV, Olin RL
    Physically "fit" for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2021 Aug 16. pii: 10.1038/s41409-021-01436.
    >> Share

  14. TAMAI H, Tajika K, Nakayama K, Arai A, et al
    Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide.
    Bone Marrow Transplant. 2021 Aug 12. pii: 10.1038/s41409-021-01432.
    >> Share

  15. MISHRA A, Pidala J, Thapa R, Betts BC, et al
    Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01428.
    >> Share

  16. OHMOTO A, Fuji S
    Cardiac complications associated with hematopoietic stem-cell transplantation.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01427.
    >> Share

  17. WU Y, Zhao Y, Wang T, Xia J, et al
    Evaluation of diagnostic performance of metagenomic next-generation sequencing when applied in patients after allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2021 Aug 10. pii: 10.1038/s41409-021-01423.
    >> Share

  18. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Aug 9. pii: 10.1038/s41409-021-01421.
    >> Share

  19. CORNILLON J, Daguenet E, Tournilhac O, Blaise D, et al
    Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire.
    Bone Marrow Transplant. 2021 Aug 6. pii: 10.1038/s41409-021-01426.
    >> Share

    July 2021
  20. NIEDERWIESER C, Morozova E, Zubarovskaya L, Zabelina T, et al
    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
    Bone Marrow Transplant. 2021 Jul 30. pii: 10.1038/s41409-021-01410.
    >> Share

  21. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.
    >> Share

  22. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    >> Share

  23. ZUCENKA A, Vaitekenaite V, Maneikis K, Davainis L, et al
    Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01416.
    >> Share

  24. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    >> Share

  25. JENTZSCH M, Grimm J, Bill M, Kupper J, et al
    Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01407.
    >> Share

  26. KONDO G, Ishimaru F, Konuma T, Takahashi S, et al
    Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01406.
    >> Share

  27. CUVELIER S, Blaise D, Boher JM, Villaron-Goetgheluck C, et al
    A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 14. pii: 10.1038/s41409-021-01401.
    >> Share

  28. LUFT T, Dreger P, Radujkovic A
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01390.
    >> Share

  29. ALARCON TOMAS A, Whiting K, Maloy M, Ruiz JD, et al
    The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01392.
    >> Share

  30. BORTNICK R, Wlodarski M, de Haas V, De Moerloose B, et al
    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Jul 9. pii: 10.1038/s41409-021-01374.
    >> Share

  31. TANG FF, Zhao XY, Huo MR, Chang YJ, et al
    Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01382.
    >> Share

  32. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    >> Share

  33. LANKESTER AC, Albert MH, Booth C, Gennery AR, et al
    EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01378.
    >> Share

  34. BAA AK, Chellapuram SK, Sharma A, Malik PS, et al
    Poems syndrome: consolidation with autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01395.
    >> Share

  35. PRYCE A, Mir F, Ushiro-Lumb I, Drypen R, et al
    SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01379.
    >> Share

  36. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    >> Share

  37. WOLFF D, Fatobene G, Rocha V, Kroger N, et al
    Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01389.
    >> Share

  38. ANSARI M, Petrykey K, Rezgui MA, Del Vecchio V, et al
    Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
    Bone Marrow Transplant. 2021 Jul 2. pii: 10.1038/s41409-021-01386.
    >> Share

  39. LUCIA A, Fiuza-Luces C
    Physical fitness and childhood hematopoietic stem cell transplantation: a call to action.
    Bone Marrow Transplant. 2021 Jul 1. pii: 10.1038/s41409-021-01397.
    >> Share

    June 2021
  40. LUPO-STANGHELLINI MT, Xue E, Mastaglio S, Oltolini C, et al
    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
    Bone Marrow Transplant. 2021 Jun 30. pii: 10.1038/s41409-021-01278.
    >> Share

  41. LEMIEUX C, Muffly LS, Iberri DJ, Craig JK, et al
    Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01371.
    >> Share

  42. GILFANOVA R, Callegari A, Childs A, Yang G, et al
    A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01368.
    >> Share

  43. FRIDH MK, Simonsen C, Schmidt-Andersen P, Nissen AA, et al
    Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01370.
    >> Share

  44. BERGERON A
    Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!
    Bone Marrow Transplant. 2021 Jun 18. pii: 10.1038/s41409-021-01381.
    >> Share

  45. FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
    Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Bone Marrow Transplant. 2021 Jun 14. pii: 10.1038/s41409-021-01367.
    >> Share

  46. BONIFAZI F, Defrancesco I, Olivieri J, Barbato F, et al
    Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01359.
    >> Share

  47. FLOISAND Y, Schroeder MA, Chevallier P, Selleslag D, et al
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01356.
    >> Share

  48. KAWASHIMA N, Nishikawa E, Tsuchisaka A, Hashimoto T, et al
    Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01335.
    >> Share

    May 2021
  49. ESQUIROL A, Pascual MJ, Kwon M, Perez A, et al
    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01328.
    >> Share

  50. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    >> Share

  51. KUMARI R, Palaniyandi S, Hildebrandt GC
    The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
    Bone Marrow Transplant. 2021 May 29. pii: 10.1038/s41409-021-01325.
    >> Share

  52. SUN X, Yang J, Cai Y, Wan L, et al
    Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
    Bone Marrow Transplant. 2021 May 25. pii: 10.1038/s41409-021-01358.
    >> Share

  53. GRECO R, Alexander T, Burman J, Del Papa N, et al
    Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01326.
    >> Share

  54. LACY M, Fong M, Bolton C, Maranzano M, et al
    Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01331.
    >> Share

  55. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    >> Share

  56. MIKULSKA M, Tridello G, Hoek J, Gil L, et al
    Legionellosis after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 22. pii: 10.1038/s41409-021-01333.
    >> Share

  57. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.
    >> Share

  58. SHIMOMURA Y, Hara M, Konuma T, Itonaga H, et al
    Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
    Bone Marrow Transplant. 2021 May 15. pii: 10.1038/s41409-021-01324.
    >> Share

  59. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    >> Share

  60. VIJENTHIRA A, Kuruvilla J, Prica A
    Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01327.
    >> Share

  61. XU L, Feng J, Xu X, Li X, et al
    IL-17-producing gammadeltaT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1(+)CD11b(+) myeloid-derived suppressor cells.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01299.
    >> Share

  62. MURATA M, Terakura S, Wake A, Miyao K, et al
    Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Bone Marrow Transplant. 2021 May 11. pii: 10.1038/s41409-021-01304.
    >> Share

  63. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 10. pii: 10.1038/s41409-021-01315.
    >> Share

  64. ALBERT MH, Sirin M, Hoenig M, Hauck F, et al
    Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Bone Marrow Transplant. 2021 May 9. pii: 10.1038/s41409-021-01323.
    >> Share

  65. DE OLIVEIRA RODRIGUES M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, et al
    Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 8. pii: 10.1038/s41409-021-01329.
    >> Share

  66. SHIRATORI S, Sugita J, Fuji S, Aoki J, et al
    Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01314.
    >> Share

  67. DERENZINI E, Tabanelli V, Sammassimo S, Mazzara S, et al
    Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01320.
    >> Share

  68. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    >> Share

  69. KALOYANNIDIS P, Ayyad A, Bahaliwah Z, Blowi B, et al
    Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01318.
    >> Share

  70. DE LA PUERTA R, Montoro J, Aznar C, Lorenzo I, et al
    Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01319.
    >> Share

  71. OOSTENBRINK LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al
    Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 3. pii: 10.1038/s41409-021-01302.
    >> Share

    April 2021
  72. TOYODA K, Yasunaga JI, Choi I, Suehiro Y, et al
    The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01311.
    >> Share

  73. HARADA K, Kimura SI, Fuji S, Najima Y, et al
    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01310.
    >> Share

  74. SAITO Y, Urashima M, Takahashi Y, Ogawa A, et al
    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01303.
    >> Share

  75. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    >> Share

  76. RAGON BK
    FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01269.
    >> Share

  77. AMONOO HL, El-Jawahri A, Celano CM, Brown LA, et al
    A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial.
    Bone Marrow Transplant. 2021 Apr 20. pii: 10.1038/s41409-021-01296.
    >> Share

  78. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
    >> Share

  79. FIALA MA, King J, Feinberg D, Goldsmith SR, et al
    Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01295.
    >> Share

  80. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    >> Share

  81. EYRE TA, Caillard S, Finel H, Boumendil A, et al
    Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2021 Apr 16. pii: 10.1038/s41409-021-01270.
    >> Share

  82. RAMDIAL JL, Mehta RS, Saliba RM, Alousi AM, et al
    Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01274.
    >> Share

  83. WU J, Fu HX, He Y, Mo XD, et al
    Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01293.
    >> Share

  84. EGLSEER D, Bauer S, Huber-Krassnitzer B, Greinix H, et al
    Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01292.
    >> Share

  85. NELSON AM, Johnson PC, Kavanaugh AR, Jackson VA, et al
    Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01281.
    >> Share

  86. BADAR T, Szabo A, Litzow M, Burkart M, et al
    Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01279.
    >> Share

  87. LIU W, Fan Z, Zhang Y, Huang F, et al
    Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01243.
    >> Share

  88. HAGHIRI S, Fayech C, Mansouri I, Dufour C, et al
    Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01258.
    >> Share

  89. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.
    >> Share

    March 2021
  90. DAHER-REYES G, Kim T, Novitzky-Basso I, Kim KH, et al
    Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01255.
    >> Share

  91. BENTO L, Gutierrez A, Novelli S, Montoro J, et al
    Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01264.
    >> Share

  92. LAZZARO C, Castagna L, Lanza F, Laszlo D, et al
    Chemotherapy-based versus chemotherapy-free stem cell mobilization (+/- plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.
    Bone Marrow Transplant. 2021 Mar 22. pii: 10.1038/s41409-021-01251.
    >> Share

  93. IMOTO H, Yoshioka S, Hiramoto N, Morita-Fujita M, et al
    Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Bone Marrow Transplant. 2021 Mar 10. pii: 10.1038/s41409-021-01263.
    >> Share

  94. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01254.
    >> Share

  95. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    >> Share

  96. KAPOOR J, Khushoo V, Garg A, Naim F, et al
    An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01256.
    >> Share

  97. SHAH RM
    Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01246.
    >> Share

  98. RUGGERI A, Labopin M, Angelucci E, Blaise D, et al
    Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01248.
    >> Share

  99. RITACCO C, Ehx G, Gregoire C, Daulne C, et al
    High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 4. pii: 10.1038/s41409-021-01221.
    >> Share

  100. REUSING SB, Manser AR, Groeneveld-Krentz S, Rebmann V, et al
    HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01231.
    >> Share

  101. ELMARIAH H, Naqvi SMH, Kim J, Nishihori T, et al
    Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01219.
    >> Share

  102. SHIMOMURA Y, Hara M, Yamamoto H, Uchida N, et al
    Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01217.
    >> Share

  103. PULIAFITO B, Zhao Y, Afshar S, Galitzeck Z, et al
    Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.
    Bone Marrow Transplant. 2021 Mar 1. pii: 10.1038/s41409-021-01240.
    >> Share

    February 2021
  104. TANG X, Valdez BC, Ma Y, Zhang Q, et al
    Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01238.
    >> Share

  105. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    >> Share

  106. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    >> Share

  107. CHRISTOPEIT M, Reichard M, Niederwieser C, Massoud R, et al
    Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01225.
    >> Share

  108. SHEIKH MA, Im A, Ballen K, Hashmi SK, et al
    Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01216.
    >> Share

  109. PAUTAS C, Raffoux E, Lambert J, Legrand O, et al
    Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-020-01207.
    >> Share

  110. RUBEN CL, Pirsl F, Steinberg SM, Holtzman NG, et al
    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-021-01211.
    >> Share

  111. PRINCE HM, Abeyakoon C
    Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome: never-late, never-never?
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-020-01150.
    >> Share

    January 2021
  112. DAI H, Penack O, Radujkovic A, Schult D, et al
    Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Bone Marrow Transplant. 2021 Jan 30. pii: 10.1038/s41409-020-01186.
    >> Share

  113. AHMED N, Li L, Rojas P, Covut F, et al
    Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01223.
    >> Share

  114. SAKURAI M, Mori T, Kato K, Kanaya M, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01192.
    >> Share

  115. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
    >> Share

  116. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01200.
    >> Share

  117. LOPEZ R, Plat G, Bertrand Y, Ducassou S, et al
    Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study.
    Bone Marrow Transplant. 2021 Jan 16. pii: 10.1038/s41409-020-01180.
    >> Share

  118. VAN LEEUWEN SJM, Proctor GB, Laheij AMGA, Potting CMJ, et al
    Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01185.
    >> Share

  119. WEI N, Wang Y, Wang J, Wu L, et al
    Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01193.
    >> Share

  120. DOMINGO-DOMENECH E, Duarte RF, Boumedil A, Onida F, et al
    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sezary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01197.
    >> Share

  121. WALLACE G, Khandelwal P, Myers KC, Perentesis EMR, et al
    Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01189.
    >> Share

  122. OKOEV G, Weisdorf DJ, Wagner JE, Blazar BR, et al
    Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01195.
    >> Share

  123. SUN X, Su Y, Liu X, Zhang Y, et al
    Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.
    Bone Marrow Transplant. 2021 Jan 7. pii: 10.1038/s41409-020-01187.
    >> Share

    December 2020
  124. GIAMMARCO S, Raiola AM, Di Grazia C, Bregante S, et al
    Second haploidentical stem cell transplantation for primary graft failure.
    Bone Marrow Transplant. 2020 Dec 16. pii: 10.1038/s41409-020-01183.
    >> Share

  125. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    >> Share

  126. SANZ J, Labopin M, Sanz MA, Aljurf M, et al
    Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01162.
    >> Share

  127. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    >> Share

  128. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    >> Share

  129. MONTORO J, Chorao P, Bento L, Cabrero M, et al
    Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01161.
    >> Share

  130. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    >> Share

  131. HIRSCHBUHL K, Labopin M, Houhou M, Gabellier L, et al
    Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Dec 9. pii: 10.1038/s41409-020-01173.
    >> Share

  132. MAZIARZ RT, Levis M, Patnaik MM, Scott BL, et al
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Dec 7. pii: 10.1038/s41409-020-01153.
    >> Share

  133. BAKER LX, Chen F, Ssempijja Y, Byrne M, et al
    Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Dec 5. pii: 10.1038/s41409-020-01158.
    >> Share

  134. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    >> Share

  135. BAI B, Wang XX, Gao Y, Li PF, et al
    Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01164.
    >> Share

  136. VAXMAN I, Visram A, Kumar S, Dispenzieri A, et al
    Autologous stem cell transplantation for multiple myeloma patients aged >/= 75 treated with novel agents.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01159.
    >> Share

  137. JABBOUR J, Manana B, Zahreddine A, Al-Shaar L, et al
    Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
    Bone Marrow Transplant. 2020 Dec 1. pii: 10.1038/s41409-020-01154.
    >> Share

    November 2020
  138. BERRO M, Rivas M, Trucco J, Paganini I, et al
    Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center exper
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01146.
    >> Share

  139. PAVIGLIANITI A, Labopin M, Blaise D, Socie G, et al
    Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01155.
    >> Share

  140. OTTH M, Schindera C, Gungor T, Ansari M, et al
    Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.
    Bone Marrow Transplant. 2020 Nov 25. pii: 10.1038/s41409-020-01137.
    >> Share

  141. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    >> Share

  142. EBBESEN M, Weischendorff S, Kielsen K, Kammersgaard M, et al
    Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01127.
    >> Share

  143. MENGLING T, Rall G, Bernas SN, Astreou N, et al
    Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01138.
    >> Share

  144. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    >> Share

  145. VAXMAN I, Sidiqi MH, Al Saleh AS, Kumar S, et al
    Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Nov 18. pii: 10.1038/s41409-020-01136.
    >> Share

  146. BLAGOV S, Zvyagin IV, Shelikhova L, Khismatullina R, et al
    T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after alphabeta T cell-depleted hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01128.
    >> Share

  147. MAAS-BAUER K, Kiote-Schmidt C, Bertz H, Apostolova P, et al
    Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01122.
    >> Share

  148. KANG HM, Kim SK, Lee JW, Chung NG, et al
    Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01121.
    >> Share

  149. CASTAGNA L, Pagliardini T, Bramanti S, Schiano de Colella JM, et al
    Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Bone Marrow Transplant. 2020 Nov 15. pii: 10.1038/s41409-020-01133.
    >> Share

  150. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    >> Share

  151. KHAN M, Iftikhar R, Ghafoor T, Hussain F, et al
    Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.
    Bone Marrow Transplant. 2020 Nov 12. pii: 10.1038/s41409-020-01126.
    >> Share

  152. GERTZ MA, Lacy MQ, Jacob EK, Hogan WJ, et al
    Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2020 Nov 11. pii: 10.1038/s41409-020-01131.
    >> Share

  153. SULTAN AM, Mahmoud HK, Fathy GM, Abdelfattah NM, et al
    The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection.
    Bone Marrow Transplant. 2020 Nov 4. pii: 10.1038/s41409-020-01094.
    >> Share

  154. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
    Bone Marrow Transplant. 2020 Nov 3. pii: 10.1038/s41409-020-01098.
    >> Share

  155. MORITA K, Fujiwara SI, Ikeda T, Kawaguchi SI, et al
    Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01096.
    >> Share

    October 2020
  156. IWAMOTO M, Ikegawa S, Kondo T, Meguri Y, et al
    Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01100.
    >> Share

  157. YOON JH, Min GJ, Park SS, Park S, et al
    Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01097.
    >> Share

  158. IRENE GC, Albert E, Anna BV, Rahinatu A, et al
    Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.
    Bone Marrow Transplant. 2020 Oct 26. pii: 10.1038/s41409-020-01092.
    >> Share

  159. EL-SERAFI A, He R, Zheng W, Benkossou F, et al
    Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.
    Bone Marrow Transplant. 2020 Oct 21. pii: 10.1038/s41409-020-01091.
    >> Share

  160. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 20. pii: 10.1038/s41409-020-01090.
    >> Share

  161. MODI D, Kim S, Deol A, Ayash L, et al
    Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Oct 16. pii: 10.1038/s41409-020-01079.
    >> Share

  162. BENTO L, Boumendil A, Finel H, Khvedelidze I, et al
    Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01075.
    >> Share

  163. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01083.
    >> Share

  164. MORISHIMA S, Fukuda T, Doki N, Mori T, et al
    Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
    Bone Marrow Transplant. 2020 Oct 9. pii: 10.1038/s41409-020-01070.
    >> Share

  165. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2020 Oct 7. pii: 10.1038/s41409-020-01053.
    >> Share

  166. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    >> Share

  167. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01069.
    >> Share

    September 2020
  168. SUGITA J, Kamimura T, Ishikawa T, Ota S, et al
    Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 24. pii: 10.1038/s41409-020-01065.
    >> Share

  169. MAAKARON JE, McKenna D Jr, El-Jurdi N, Arora M, et al
    COVID19 seroconversion in an unrelated stem cell donor.
    Bone Marrow Transplant. 2020 Sep 22. pii: 10.1038/s41409-020-01066.
    >> Share

  170. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    >> Share

  171. SALEH W, Katz J
    Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01057.
    >> Share

  172. ZAMPERLINI-NETTO G, Fernandes JF, Garcia JL, Ribeiro AAF, et al
    COVID-19 after hematopoietic stem cell transplantation: report of two children.
    Bone Marrow Transplant. 2020 Sep 16. pii: 10.1038/s41409-020-01041.
    >> Share

  173. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Sep 8. pii: 10.1038/s41409-020-01049.
    >> Share

  174. JIANG S, Fan Y, Fang Y, Hou C, et al
    The role of EVI1 gene quantification in AML patients with 11q23/MLL rearrangement after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 5. pii: 10.1038/s41409-020-01048.
    >> Share

  175. MEJDAHL NIELSEN M, Mathiesen S, Suominen A, Sorensen K, et al
    Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism.
    Bone Marrow Transplant. 2020 Sep 2. pii: 10.1038/s41409-020-01038.
    >> Share

  176. SHIMONI A, Shem-Tov N, Yerushalmi R, Danylesko I, et al
    Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2020 Sep 2. pii: 10.1038/s41409-020-01044.
    >> Share

  177. XU X, Yang J, Cai Y, Li S, et al
    Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem
    Bone Marrow Transplant. 2020 Sep 1. pii: 10.1038/s41409-020-01047.
    >> Share

    August 2020
  178. POLITIKOS I, Mazis CM, Naputo KA, Skinner K, et al
    Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units.
    Bone Marrow Transplant. 2020 Aug 29. pii: 10.1038/s41409-020-01042.
    >> Share

  179. EVEN-OR E, NaserEddin A, Dinur Schejter Y, Shadur B, et al
    Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases.
    Bone Marrow Transplant. 2020 Aug 27. pii: 10.1038/s41409-020-01040.
    >> Share

  180. PETER K, Siska PJ, Roider T, Matos C, et al
    1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 27. pii: 10.1038/s41409-020-01031.
    >> Share

  181. SAHIN U, Soydan E, Gokmen A, Ozcan M, et al
    Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 26. pii: 10.1038/s41409-020-01043.
    >> Share

  182. LU X, Tang LV, Wang HF, You Y, et al
    The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19.
    Bone Marrow Transplant. 2020 Aug 25. pii: 10.1038/s41409-020-01035.
    >> Share

  183. ROH YY, Hahn SM, Kim HS, Ahn WK, et al
    Efficacy of low dose and short duration defibrotide prophylaxis for hepatic veno-occlusive disease after autologous haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 24. pii: 10.1038/s41409-020-01036.
    >> Share

  184. HARADA K, Fuji S, Seo S, Uchida N, et al
    Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 20. pii: 10.1038/s41409-020-00999.
    >> Share

  185. PREM S, Remberger M, Salas MQ, Al-Shaibani Z, et al
    Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies.
    Bone Marrow Transplant. 2020 Aug 14. pii: 10.1038/s41409-020-01030.
    >> Share

  186. LAURENT V, Fronteau C, Antier C, Dupuis P, et al
    Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience.
    Bone Marrow Transplant. 2020 Aug 14. pii: 10.1038/s41409-020-01033.
    >> Share

  187. LEMIEUX C, Muffly LS, Rezvani A, Lowsky R, et al
    Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma.
    Bone Marrow Transplant. 2020 Aug 11. pii: 10.1038/s41409-020-01026.
    >> Share

  188. FUJIMOTO A, Ishida F, Izutsu K, Yamasaki S, et al
    Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemia.
    Bone Marrow Transplant. 2020 Aug 10. pii: 10.1038/s41409-020-01009.
    >> Share

  189. SHIBAMIYA A, Ohwada C, Ishii A, Mishina T, et al
    Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
    Bone Marrow Transplant. 2020 Aug 10. pii: 10.1038/s41409-020-01024.
    >> Share

  190. MCCAUGHAN G, Ma D, Moore J
    Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01025.
    >> Share

  191. EL-HARASIS MA, Hefazi M, Julakanti R, Hogan WJ, et al
    Cardiovascular outcomes in patients receiving myeloablative vs. reduced intensity conditioning prior to allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01021.
    >> Share

  192. STAMOULI M, Tsonis I, Gkirkas K, Economopoulou C, et al
    Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 8. pii: 10.1038/s41409-020-01022.
    >> Share

  193. SHI J, Cao L, Luo Y, Zhao Y, et al
    Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Aug 4. pii: 10.1038/s41409-020-01015.
    >> Share

    July 2020
  194. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
    Bone Marrow Transplant. 2020 Jul 31. pii: 10.1038/s41409-020-01017.
    >> Share

  195. GAGELMANN N, Eikema DJ, de Wreede LC, Rambaldi A, et al
    Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT.
    Bone Marrow Transplant. 2020 Jul 24. pii: 10.1038/s41409-020-01007.
    >> Share

  196. JEPPESEN H, Sengelov H, Eriksson F, Kiilgaard JF, et al
    Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark - factors associated with risks and rates in adults according to conditioning regimen.
    Bone Marrow Transplant. 2020 Jul 12. pii: 10.1038/s41409-020-0993.
    >> Share

  197. DEBUREAUX PE, Sicre de Fontbrune F, Bonfim C, Dalle JH, et al
    FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study.
    Bone Marrow Transplant. 2020 Jul 10. pii: 10.1038/s41409-020-0994.
    >> Share

  198. MEDVEDOVA E, Strasfeld L, Stenzel P, Maziarz RT, et al
    Autopsy among recipients of stem cell transplant for hematologic malignancies in the modern era.
    Bone Marrow Transplant. 2020 Jul 8. pii: 10.1038/s41409-020-0992.
    >> Share

  199. MAUNG KK, Chen BJ, Barak I, Li Z, et al
    Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 5. pii: 10.1038/s41409-020-0991.
    >> Share

  200. SHIRATORI S, Sugita J, Ota S, Kasahara S, et al
    Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 5. pii: 10.1038/s41409-020-0985.
    >> Share

  201. AGRAWAL V, Ranganath P, Ervin KD, Schmidt CA, et al
    Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome.
    Bone Marrow Transplant. 2020 Jul 4. pii: 10.1038/s41409-020-0987.
    >> Share

  202. AL SALEH AS, Parmar HV, Vaxman I, Visram A, et al
    Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Jul 4. pii: 10.1038/s41409-020-0990.
    >> Share

  203. BURT RK, Han X, Quigley K, Arnautovic I, et al
    Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days.
    Bone Marrow Transplant. 2020 Jul 1. pii: 10.1038/s41409-020-0978.
    >> Share

    June 2020
  204. FRIETSCH JJ, Hunstig F, Wittke C, Junghanss C, et al
    Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity.
    Bone Marrow Transplant. 2020 Jun 30. pii: 10.1038/s41409-020-0984.
    >> Share

  205. PAGLIUCA S, Prata PH, Xhaard A, Frieri C, et al
    Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jun 25. pii: 10.1038/s41409-020-0977.
    >> Share

  206. GU B, Shi BY, Zhang X, Zhou SY, et al
    Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells.
    Bone Marrow Transplant. 2020 Jun 24. pii: 10.1038/s41409-020-0982.
    >> Share

  207. IKEGAME K, Kaida K, Fukunaga K, Osugi Y, et al
    Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.
    Bone Marrow Transplant. 2020 Jun 20. pii: 10.1038/s41409-020-0980.
    >> Share

  208. SANTOSA D, Pangarsa EA, Setiawan B, Naibaho RM, et al
    Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia.
    Bone Marrow Transplant. 2020 Jun 17. pii: 10.1038/s41409-020-0973.
    >> Share

  209. MERLI M, Luminari S, Farina L, Cocito F, et al
    Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0967.
    >> Share

  210. NIU A, McDougal A, Ning B, Safa F, et al
    COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0972.
    >> Share

  211. YANG L, Tan Y, Shi J, Zhao Y, et al
    Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0962.
    >> Share

  212. ANURATHAPAN U, Apiwattanakul N, Pakakasama S, Pongphitcha P, et al
    Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
    Bone Marrow Transplant. 2020 Jun 11. pii: 10.1038/s41409-020-0969.
    >> Share

  213. ABDALLAH N, Sidana S, Dispenzieri A, Lacy M, et al
    Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Jun 9. pii: 10.1038/s41409-020-0964.
    >> Share

  214. BUCHTELE N, Rabitsch W, Knaus HA, Wohlfarth P, et al
    Containment of a traceable COVID-19 outbreak among healthcare workers at a hematopoietic stem cell transplantation unit.
    Bone Marrow Transplant. 2020 Jun 1. pii: 10.1038/s41409-020-0958.
    >> Share

    May 2020
  215. BURT RK, Craig R, Yun L, Halverson A, et al
    A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease.
    Bone Marrow Transplant. 2020 May 28. pii: 10.1038/s41409-020-0953.
    >> Share

  216. LI L, Kolk M, Fernandez-Vina M, de Lima M, et al
    Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantation.
    Bone Marrow Transplant. 2020 May 27. pii: 10.1038/s41409-020-0957.
    >> Share

  217. PURTILL D, Cirillo M, Fogarty J, Tan D, et al
    Early cessation of a randomised study in acute graft versus host disease: upfront mesenchymal stromal cells with corticosteroids versus corticosteroids alone.
    Bone Marrow Transplant. 2020 May 27. pii: 10.1038/s41409-020-0955.
    >> Share

  218. HUNTLEY D, Gimenez E, Pascual MJ, Vazquez L, et al
    Peripheral blood regulatory T cells and occurrence of Cytomegalovirus DNAemia after unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0950.
    >> Share

  219. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0952.
    >> Share

  220. VAN DE WYNGAERT Z, Nerich V, Fouquet G, Chretien ML, et al
    Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0940.
    >> Share

  221. YOSHIDA N, Takahashi Y, Yabe H, Kobayashi R, et al
    Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0948.
    >> Share

  222. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2020 May 22. pii: 10.1038/s41409-020-0946.
    >> Share

  223. NACHEVA E, Ahyee T, Addada J, Navarette C, et al
    Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.
    Bone Marrow Transplant. 2020 May 21. pii: 10.1038/s41409-020-0945.
    >> Share

  224. LEVY-BARAZANY H, Shachnai-Pinkas L, Rodionov G, Saar A, et al
    Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance.
    Bone Marrow Transplant. 2020 May 20. pii: 10.1038/s41409-020-0941.
    >> Share

  225. LEV-SAGIE A, Adar-Walling E, Gumer A, Grisariu S, et al
    Management and long-term consequences of genital graft versus host disease following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0933.
    >> Share

  226. SUREDA A, Genadieva Stavrik S, Boumendil A, Finel H, et al
    Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2020 May 15. pii: 10.1038/s41409-020-0929.
    >> Share

  227. MOTAEI J, Yaghmaie M, Pashaiefar H, Mousavi SA, et al
    Differential microRNAs expression in acute graft-versus-host disease as potential diagnostic biomarkers.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0949.
    >> Share

  228. DAMLAJ M, Abuelgasim KA, Alhejazi A, Alahmari B, et al
    Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0935.
    >> Share

  229. POLVERELLI N, Tura P, Battipaglia G, Malagola M, et al
    Multidimensional geriatric assessment for elderly hematological patients (>/=60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients.
    Bone Marrow Transplant. 2020 May 12. pii: 10.1038/s41409-020-0934.
    >> Share

  230. ROBESOVA B, Drncova M, Folta A, Krejci M, et al
    Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR.
    Bone Marrow Transplant. 2020 May 9. pii: 10.1038/s41409-020-0938.
    >> Share

  231. CHANG YJ, Xu LP, Wang Y, Zhang XH, et al
    Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody.
    Bone Marrow Transplant. 2020 May 8. pii: 10.1038/s41409-020-0928.
    >> Share

  232. FANTOZZI PJ, Treister NS, Cutler CS, Villa A, et al
    Oral health in allogeneic hematopoietic stem cells transplantation survivors.
    Bone Marrow Transplant. 2020 May 7. pii: 10.1038/s41409-020-0927.
    >> Share

  233. REES MJ, Spencer A, Browett P, Alvaro F, et al
    High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission.
    Bone Marrow Transplant. 2020 May 6. pii: 10.1038/s41409-020-0924.
    >> Share

  234. COOPERRIDER JH, Fulton N, Artz AS, Larson RA, et al
    Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2020 May 6. pii: 10.1038/s41409-020-0925.
    >> Share

  235. GERGIS U, Reich-Slotky R, Abdulahad B
    Gastric bypass bariatric surgery in patients undergoing allogeneic hematopoietic stem cell transplantation warrants special considerations.
    Bone Marrow Transplant. 2020 May 5. pii: 10.1038/s41409-020-0922.
    >> Share

  236. MONTORO J, Pinana JL, Hernandez-Boluda JC, Hernani R, et al
    Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors.
    Bone Marrow Transplant. 2020 May 5. pii: 10.1038/s41409-020-0921.
    >> Share

  237. SAHU KK, Siddiqui AD, Cerny J
    COVID-19 pandemic and impact on hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 4. pii: 10.1038/s41409-020-0913.
    >> Share

  238. BUHLER S, Baldomero H, Ferrari-Lacraz S, Nunes JM, et al
    Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 May 4. pii: 10.1038/s41409-020-0862.
    >> Share

  239. PERIC Z, Labopin M, Peczynski C, Polge E, et al
    Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT.
    Bone Marrow Transplant. 2020 May 2. pii: 10.1038/s41409-020-0878.
    >> Share

  240. AL SALEH AS, Sidiqi MH, Lee J, Dispenzieri A, et al
    Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant.
    Bone Marrow Transplant. 2020 May 1. pii: 10.1038/s41409-020-0916.
    >> Share

  241. OLRY DE LABRY LIMA A, Matas Hoces A, Gimeno Ballester V, Rios Sanchez E, et al
    Cost-effectiveness of lenalidomide.
    Bone Marrow Transplant. 2020;55:853-854.
    >> Share

  242. DHANASIRI S
    Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.
    Bone Marrow Transplant. 2020;55:987-988.
    >> Share

    April 2020
  243. NOVAK P, Klyuchnikov E, von Pein UM, Gullstorf M, et al
    Second allogeneic stem cell transplantation for relapse after allografting in multiple myeloma using CD 34+ selected donor cells without immunosuppression.
    Bone Marrow Transplant. 2020 Apr 29. pii: 10.1038/s41409-020-0912.
    >> Share

  244. ELGOHARY G, El Fakih R, de Latour R, Risitano A, et al
    Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAW
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0897.
    >> Share

  245. DI RENZO N, Musso M, Scime R, Cupri A, et al
    Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantat
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0909.
    >> Share

  246. CAI X, Fu HX, Mo XD, Wang Y, et al
    Comparison of hemorrhagic and ischemic stroke after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Apr 24. pii: 10.1038/s41409-020-0903.
    >> Share

  247. LEIPER A, Houwing M, Davies EG, Rao K, et al
    Correction: Anti-Mullerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens.
    Bone Marrow Transplant. 2020 Apr 24. pii: 10.1038/s41409-020-0914.
    >> Share

  248. LAURENT C, Marjanovic Z, Ricard L, Henes J, et al
    Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blo
    Bone Marrow Transplant. 2020 Apr 22. pii: 10.1038/s41409-020-0907.
    >> Share

  249. CHEN Q, Zhao X, Fu HX, Chen YH, et al
    Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2020 Apr 18. pii: 10.1038/s41409-020-0894.
    >> Share

  250. JO JC, Kim JS, Lee JH, Lee JH, et al
    Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL).
    Bone Marrow Transplant. 2020 Apr 17. pii: 10.1038/s41409-020-0908.
    >> Share

  251. AL-MOFAREH M, Ayas M, Al-Seraihy A, Siddiqui K, et al
    Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0885.
    >> Share

  252. MERLI P, Vacca P, Galaverna F, Tumino N, et al
    TCRalphabeta/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0891.
    >> Share

  253. CARAPITO R, Aouadi I, Pichot A, Spinnhirny P, et al
    Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
    Bone Marrow Transplant. 2020 Apr 14. pii: 10.1038/s41409-020-0886.
    >> Share

  254. FANTOZZI PJ, Villa A, Antin JH, Treister N, et al
    Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0889.
    >> Share

  255. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Bloo
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0901.
    >> Share

  256. KHANDELWAL P, Fukuda T, Teusink-Cross A, Kashuba ADM, et al
    CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0888.
    >> Share

  257. UZIEL O, Lahav M, Shargian L, Beery E, et al
    Correction: Premature ageing following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Apr 8. pii: 10.1038/s41409-020-0900.
    >> Share

    March 2020
  258. LEIPER A, Houwing M, Davies EG, Rao K, et al
    Anti-Mullerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens.
    Bone Marrow Transplant. 2020 Mar 30. pii: 10.1038/s41409-020-0866.
    >> Share

  259. EHMANN MA, Medinger M, Bodenmann B, Kraft S, et al
    Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host dis
    Bone Marrow Transplant. 2020 Mar 30. pii: 10.1038/s41409-020-0880.
    >> Share

  260. LIU L, Zhang Y, Jiao W, Zhou H, et al
    Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases.
    Bone Marrow Transplant. 2020 Mar 26. pii: 10.1038/s41409-020-0874.
    >> Share

  261. JEKER B, Farag S, Taleghani BM, Novak U, et al
    A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients.
    Bone Marrow Transplant. 2020 Mar 25. pii: 10.1038/s41409-020-0875.
    >> Share

  262. HUNTLEY D, Gimenez E, Pascual MJ, Remigia MJ, et al
    Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0865.
    >> Share

  263. SZER J, Weisdorf D, Querol S, Foeken L, et al
    The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage.
    Bone Marrow Transplant. 2020 Mar 23. pii: 10.1038/s41409-020-0873.
    >> Share

  264. KALWAK K, Mielcarek M, Patrick K, Styczynski J, et al
    Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0869.
    >> Share

  265. SUZUKI T, Kawada JI, Nishikawa E, Torii Y, et al
    Association between graft source and response to live-attenuated vaccination in pediatric hematopoietic stem cell transplantation recipients: a single-center retrospective study.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0867.
    >> Share

  266. ROVIRA M, Villamor N, Cobo F, Fernandez-Aviles F, et al
    Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation.
    Bone Marrow Transplant. 2020 Mar 20. pii: 10.1038/s41409-020-0861.
    >> Share

  267. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow
    Bone Marrow Transplant. 2020 Mar 19. pii: 10.1038/s41409-020-0863.
    >> Share

  268. TANG X, Zhang Y, Jing Y, Lu W, et al
    Allogeneic hematopoietic stem cell transplantation using unrelated cord blood or unmanipulated haploidentical donors is effective in pediatric chronic granulomatous disease with inflammatory complications and severe infection.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0864.
    >> Share

  269. BRISSOT E, Labopin M, Russo D, Martin S, et al
    Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0849.
    >> Share

  270. PICHEREAU C, Lengline E, Valade S, Michonneau D, et al
    Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score.
    Bone Marrow Transplant. 2020 Mar 17. pii: 10.1038/s41409-020-0857.
    >> Share

  271. BACIGALUPO A, Angelucci E, Raiola AM, Varaldo R, et al
    Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab.
    Bone Marrow Transplant. 2020 Mar 13. pii: 10.1038/s41409-020-0855.
    >> Share

  272. YAMASHITA T, Takami A, Uchida N, Fukuda T, et al
    Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan.
    Bone Marrow Transplant. 2020 Mar 12. pii: 10.1038/s41409-020-0856.
    >> Share

  273. KANDA J, Umeda K, Kato K, Murata M, et al
    Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation.
    Bone Marrow Transplant. 2020 Mar 11. pii: 10.1038/s41409-020-0853.
    >> Share

  274. ANAGNOSTOU T, Sakemura R, Forsman CL, Patnaik MS, et al
    Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes.
    Bone Marrow Transplant. 2020 Mar 11. pii: 10.1038/s41409-020-0851.
    >> Share

  275. GLUCKMAN E, Fuente J, Cappelli B, Scigliuolo GM, et al
    The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0847.
    >> Share

  276. PATEL SS, Lapin B, Majhail NS, Hamilton BK, et al
    Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0850.
    >> Share

  277. BASTOS-OREIRO M, Balsalobre P, Miralles P, Berenguer J, et al
    Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.
    Bone Marrow Transplant. 2020 Mar 4. pii: 10.1038/s41409-020-0846.
    >> Share

  278. MORLAND B, Kepak T, Dallorso S, Sevilla J, et al
    Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC).
    Bone Marrow Transplant. 2020 Mar 3. pii: 10.1038/s41409-020-0836.
    >> Share

  279. BLAISE D, Calvin S, Cuvelier S, Ben Soussan P, et al
    REBOUND "Trained to live again": The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantation.
    Bone Marrow Transplant. 2020 Mar 2. pii: 10.1038/s41409-020-0845.
    >> Share

  280. HONG Y, Liu L, Chang Y, Wang Y, et al
    CD8(+)CD161(hi) T cells are associated with acute graft-versus-host disease after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Mar 2. pii: 10.1038/s41409-020-0842.
    >> Share

    February 2020
  281. UZIEL O, Lahav M, Shragian L, Beery E, et al
    Premature ageing following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 24. pii: 10.1038/s41409-020-0839.
    >> Share

  282. CUESTA-MATEOS C, Portero-Sainz I, Garcia-Peydro M, Alcain J, et al
    Evaluation of therapeutic targeting of CCR7 in acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Feb 21. pii: 10.1038/s41409-020-0830.
    >> Share

  283. NAVA T, Ansari M, Dalle JH, de Heredia CD, et al
    Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Tr
    Bone Marrow Transplant. 2020 Feb 20. pii: 10.1038/s41409-020-0838.
    >> Share

  284. MOISEEV IS, Morozova EV, Bykova TA, Paina OV, et al
    Long-term outcomes of ruxolitinib therapy in steroid-refractory graft-versus-host disease in children and adults.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0834.
    >> Share

  285. SWARTLING L, Norden R, Samuelsson E, Boriskina K, et al
    Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0823.
    >> Share

  286. NISHIKAWA K, Kimura K, Kanda Y, Sugiyama M, et al
    A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0833.
    >> Share

  287. ACHINI FR, Smiers F, Jan Zwaginga J, van Tol MJD, et al
    Plasmapheresis to eliminate immunosuppressive alemtuzumab levels in a child with disseminated adenovirus infection after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 18. pii: 10.1038/s41409-020-0837.
    >> Share

  288. SHOUVAL R, Teper O, Fein JA, Danylesko I, et al
    LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell.
    Bone Marrow Transplant. 2020 Feb 17. pii: 10.1038/s41409-020-0829.
    >> Share

  289. RU Y, Zhang X, Song T, Ding Y, et al
    Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes.
    Bone Marrow Transplant. 2020 Feb 17. pii: 10.1038/s41409-020-0831.
    >> Share

  290. SZER J
    Is there no place like home for an allogeneic stem cell transplant?
    Bone Marrow Transplant. 2020 Feb 14. pii: 10.1038/s41409-020-0828.
    >> Share

  291. YOO JW, Im HJ, Kim H, Koh KN, et al
    Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome.
    Bone Marrow Transplant. 2020 Feb 13. pii: 10.1038/s41409-020-0814.
    >> Share

  292. GRONVOLD B, Ali MM, Remberger M, Mattsson J, et al
    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 13. pii: 10.1038/s41409-020-0827.
    >> Share

  293. HARADA K, Fuji S, Seo S, Kanda J, et al
    Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 12. pii: 10.1038/s41409-020-0821.
    >> Share

  294. KAITO S, Najima Y, Harada K, Fukuda T, et al
    Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0816.
    >> Share

  295. YOKOYAMA Y, Maie K, Fukuda T, Uchida N, et al
    A high CD34(+) cell dose is associated with better disease-free survival in patients with low-risk diseases undergoing peripheral blood stem cell transplantation from HLA-matched related donors.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0817.
    >> Share

  296. STEVEN P, Faust C, Holtick U, Scheid C, et al
    Adverse environmental conditions are a risk factor for ocular GvHD after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Feb 10. pii: 10.1038/s41409-020-0824.
    >> Share

  297. NAVA T, Ansari M, Dalle JH, de Heredia CD, et al
    Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantatio
    Bone Marrow Transplant. 2020 Feb 6. pii: 10.1038/s41409-020-0818.
    >> Share

  298. ALI N, Cooper B, Tomlinson B, Metheny L, et al
    Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration.
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0812.
    >> Share

  299. ALDAWSARI G, Elhaddad A, El Fakih R, Ben Othman T, et al
    Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT).
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0809.
    >> Share

  300. ZHANG P, Liu B
    Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis.
    Bone Marrow Transplant. 2020 Feb 4. pii: 10.1038/s41409-020-0810.
    >> Share

    January 2020
  301. WETHMAR K, Matern S, Esseling E, Angenendt L, et al
    Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2020 Jan 30. pii: 10.1038/s41409-020-0801.
    >> Share

  302. SAGLIO F, Zecca M, Pagliara D, Giorgiani G, et al
    Occurrence of long-term effects after hematopoietic stem cell transplantation in children affected by acute leukemia receiving either busulfan or total body irradiation: results of an AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) retro
    Bone Marrow Transplant. 2020 Jan 29. pii: 10.1038/s41409-020-0806.
    >> Share

  303. YAN CH, Wang Y, Mo XD, Sun YQ, et al
    Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0790.
    >> Share

  304. KAKINOKI Y, Ishio T, Kimura H, Shimono J, et al
    Successful salvage treatment with antithymocyte globulin for patients with early-onset hemophagocytic lymphohistiocytosis refractory to steroid and etoposide therapy following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Jan 28. pii: 10.1038/s41409-020-0802.
    >> Share

  305. DI GIUSEPPE G, Thacker N, Schechter T, Pole JD, et al
    Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoietic stem cell transplantation: a systematic review.
    Bone Marrow Transplant. 2020 Jan 24. pii: 10.1038/s41409-020-0782.
    >> Share

  306. BONIFAZI F, Rubio MT, Bacigalupo A, Boelens JJ, et al
    Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.
    Bone Marrow Transplant. 2020 Jan 22. pii: 10.1038/s41409-020-0792.
    >> Share

  307. AL-HASHMI H, Alsagheir A, Estanislao A, Bacal J, et al
    Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration.
    Bone Marrow Transplant. 2020 Jan 21. pii: 10.1038/s41409-020-0793.
    >> Share

  308. DEBUREAUX PE, Febvre de Nailly DL, Tavernier E, Bedoui M, et al
    Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0796.
    >> Share

  309. OTHMAN J, Armytage T, Wong K, Arthur C, et al
    Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0789.
    >> Share

  310. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0788.
    >> Share

  311. HUESO T, Gastinne T, Garciaz S, Tchernonog E, et al
    Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers.
    Bone Marrow Transplant. 2020 Jan 17. pii: 10.1038/s41409-020-0783.
    >> Share

  312. FUJI S, Nagler A, Mohty M, Savani B, et al
    Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy.
    Bone Marrow Transplant. 2020 Jan 13. pii: 10.1038/s41409-020-0784.
    >> Share

  313. MA YR, Wang WJ, Cheng YF, Zhang YY, et al
    Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.
    Bone Marrow Transplant. 2020 Jan 13. pii: 10.1038/s41409-020-0779.
    >> Share

  314. YIN X, Hu L, Zhang Y, Zhu C, et al
    Correction: PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
    Bone Marrow Transplant. 2020 Jan 10. pii: 10.1038/s41409-020-0781.
    >> Share

  315. BECK A, Lin R, Reza Rejali A, Rubens M, et al
    Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
    Bone Marrow Transplant. 2020 Jan 2. pii: 10.1038/s41409-019-0777.
    >> Share

    December 2019
  316. ALEXANDER T, Samuelson C, Daikeler T, Henes J, et al
    Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry.
    Bone Marrow Transplant. 2019 Dec 17. pii: 10.1038/s41409-019-0763.
    >> Share

  317. ZHANG H, Hu Y, Wei G, Wu W, et al
    Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Dec 17. pii: 10.1038/s41409-019-0778.
    >> Share

  318. RYAN AL, Wadia UD, Jacoby P, Cheung LC, et al
    Immunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplant.
    Bone Marrow Transplant. 2019 Dec 10. pii: 10.1038/s41409-019-0770.
    >> Share

  319. JENKYN I, Woodward G, Kelly A, Fowell C, et al
    Oral verruciform xanthoma associated with stem cell transplantation and graft versus host disease in a paediatric patient.
    Bone Marrow Transplant. 2019 Dec 10. pii: 10.1038/s41409-019-0772.
    >> Share

  320. KATO M, Nakasone H, Nakano N, Fuji S, et al
    Clinical course of autologous recovery with chromosomal abnormalities after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Dec 9. pii: 10.1038/s41409-019-0765.
    >> Share

  321. YIN X, Hu L, Zhang Y, Zhu C, et al
    PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.
    Bone Marrow Transplant. 2019 Dec 5. pii: 10.1038/s41409-019-0766.
    >> Share

  322. NEWMARCH M, Kostantin E, Tsongalis GJ, Guimond M, et al
    MicroRNAs in graft-versus-host disease: a review of the latest data.
    Bone Marrow Transplant. 2019 Dec 3. pii: 10.1038/s41409-019-0764.
    >> Share

    November 2019
  323. SIDHARTHAN N, Fuchs E, Unni M, Mony U, et al
    HLA-mismatched microtransplantation for relapsed or refractory acute myeloid leukemia as a bridge to allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 29. pii: 10.1038/s41409-019-0761.
    >> Share

  324. GJAERDE LK, Andersen NS, Friis LS, Kornblit B, et al
    Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 26. pii: 10.1038/s41409-019-0760.
    >> Share

  325. TOLOMELLI G, Mancuso K, Tacchetti P, Patriarca F, et al
    The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
    Bone Marrow Transplant. 2019 Nov 25. pii: 10.1038/s41409-019-0756.
    >> Share

  326. SHIROSHITA K, Mori T, Kato J, Sakurai M, et al
    Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention.
    Bone Marrow Transplant. 2019 Nov 21. pii: 10.1038/s41409-019-0755.
    >> Share

  327. SNOWDEN JA, Saccardi R, Orchard K, Ljungman P, et al
    Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and
    Bone Marrow Transplant. 2019 Nov 21. pii: 10.1038/s41409-019-0740.
    >> Share

  328. OGATA M, Uchida N, Fukuda T, Ikegame K, et al
    Clinical practice recommendations for the diagnosis and management of human herpesvirus-6B encephalitis after allogeneic hematopoietic stem cell transplantation: the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0752.
    >> Share

  329. TAPPENDEN P, Wang Y, Sharrack B, Burman J, et al
    Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Workin
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0747.
    >> Share

  330. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0745.
    >> Share

  331. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0751.
    >> Share

  332. MAYO SJ, Messner HA, Rourke SB, Howell D, et al
    Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0746.
    >> Share

  333. ABDALLAH N, Kim S, Ayash L, Klimecki S, et al
    Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
    Bone Marrow Transplant. 2019 Nov 18. pii: 10.1038/s41409-019-0744.
    >> Share

  334. ESCAMILLA GOMEZ V, Garcia-Gutierrez V, Lopez Corral L, Garcia Cadenas I, et al
    Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
    Bone Marrow Transplant. 2019 Nov 7. pii: 10.1038/s41409-019-0731.
    >> Share

  335. MOUKALLED N, Bou Akl I, Al Masri A, Kanafani Z, et al
    Non-irradiated GCSF stimulated leukocyte transfusion for necrotizing fasciitis after allogeneic stem cell transplant: a case report and review of the literature.
    Bone Marrow Transplant. 2019 Nov 7. pii: 10.1038/s41409-019-0743.
    >> Share

  336. DOMINGO-DOMENECH E, Boumendil A, Climent F, Sengeloev H, et al
    Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0734.
    >> Share

  337. DOMINGO-DOMENECH E, Boumendil A, Climent F, Socie G, et al
    Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0732.
    >> Share

  338. SCHULTZE-FLOREY CR, Peczynski C, de Marino I, Polge E, et al
    Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0738.
    >> Share

  339. BUENO JL, Alegre A, Lopez-Villar O, Querol S, et al
    Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document.
    Bone Marrow Transplant. 2019 Nov 6. pii: 10.1038/s41409-019-0716.
    >> Share

  340. YOKOYAMA E, Hashimoto D, Hayase E, Ara T, et al
    Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis.
    Bone Marrow Transplant. 2019 Nov 4. pii: 10.1038/s41409-019-0733.
    >> Share

    October 2019
  341. DETEIX C, Mesnil F, Furst S, Milpied N, et al
    Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0722.
    >> Share

  342. DU S, He W, Yang Y, Gao X, et al
    Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0736.
    >> Share

  343. RYAN AL, Wadia UD, Jacoby P, Cheung LC, et al
    Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.
    Bone Marrow Transplant. 2019 Oct 28. pii: 10.1038/s41409-019-0728.
    >> Share

  344. MORKIS IVC, Vicente BM, Habigzang M, da Silva PO, et al
    Should we evaluate intestinal microbiota of pediatric patients undergoing hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2019 Oct 28. pii: 10.1038/s41409-019-0727.
    >> Share

  345. LEICK M, Hunter B, DeFilipp Z, Dey BR, et al
    Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases.
    Bone Marrow Transplant. 2019 Oct 24. pii: 10.1038/s41409-019-0725.
    >> Share

  346. HEINICKE T, Labopin M, Polge E, Niederwieser D, et al
    Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (>/=60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2019 Oct 23. pii: 10.1038/s41409-019-0720.
    >> Share

  347. LIN RJ, Sanchez M, Abbi K, Devlin SM, et al
    Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft.
    Bone Marrow Transplant. 2019 Oct 23. pii: 10.1038/s41409-019-0723.
    >> Share

  348. SNOWDEN JA, Saccardi R, Orchard K, Ljungman P, et al
    Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Ac
    Bone Marrow Transplant. 2019 Oct 21. pii: 10.1038/s41409-019-0718.
    >> Share

  349. HENDRAWAN K, Visweswaran M, Ma DDF, Moore JJ, et al
    Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases.
    Bone Marrow Transplant. 2019 Oct 16. pii: 10.1038/s41409-019-0710.
    >> Share

  350. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Correction: Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Oct 4. pii: 10.1038/s41409-019-0706.
    >> Share

    September 2019
  351. PUERTA-ALCALDE P, Cardozo C, Marco F, Suarez-Lledo M, et al
    Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0701.
    >> Share

  352. BAZARBACHI AH, Al Hamed R, Labopin M, Afanasyev B, et al
    Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2019 Sep 27. pii: 10.1038/s41409-019-0702.
    >> Share

  353. STOCKER N, Labopin M, Boussen I, Paccoud O, et al
    Pre-emptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes.
    Bone Marrow Transplant. 2019 Sep 27. pii: 10.1038/s41409-019-0699.
    >> Share

  354. SHARRACK B, Saccardi R, Alexander T, Badoglio M, et al
    Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0684.
    >> Share

  355. FELIU J, Potter V, Grimaldi F, Clay J, et al
    Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI).
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0695.
    >> Share

  356. LUFT T, Benner A, Terzer T, Jodele S, et al
    EASIX and mortality after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0703.
    >> Share

  357. YE Y, Ricard L, Stocker N, Mohty M, et al
    A novel mouse model of acute graft-versus-host disease based on chemotherapy conditioning and G-CSF mobilized graft.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0700.
    >> Share

  358. LI AY, Atenafu EG, Bernard RS, Masih-Khan E, et al
    Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras.
    Bone Marrow Transplant. 2019 Sep 26. pii: 10.1038/s41409-019-0697.
    >> Share

  359. DEBUREAUX PE, Labopin M, Mamez AC, Lapusan S, et al
    Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0690.
    >> Share

  360. ZEBISCH A, Winter G, Kashofer K, Hatzl S, et al
    The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0691.
    >> Share

  361. MILLER PDE, Snowden JA, De Latour RP, Iacobelli S, et al
    Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0680.
    >> Share

  362. PINANA JL, Perez A, Montoro J, Hernani R, et al
    The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0698.
    >> Share

  363. PARK SS, Min GJ, Park S, Lee SE, et al
    Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0696.
    >> Share

  364. CABALLERO-VELAZQUEZ T, Calderon-Cabrera C, Lopez-Corral L, Puig N, et al
    Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0670.
    >> Share

  365. GONZALEZ-BARCA E, Boumendil A, Blaise D, Trneny M, et al
    Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantati
    Bone Marrow Transplant. 2019 Sep 20. pii: 10.1038/s41409-019-0650.
    >> Share

  366. LIN Q, Liu X, Han L, Liu L, et al
    Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myeloma.
    Bone Marrow Transplant. 2019 Sep 19. pii: 10.1038/s41409-019-0674.
    >> Share

  367. RICCI A, Jin Z, Broglie L, Bhatia M, et al
    Healthcare utilization and financial impact of acute-graft-versus host disease among children undergoing allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 Sep 19. pii: 10.1038/s41409-019-0688.
    >> Share

  368. TIRIBELLI M, Palandri F, Sant'Antonio E, Breccia M, et al
    The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0683.
    >> Share

  369. NYKOLYSZYN C, Granata A, Pagliardini T, Castagna L, et al
    Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0682.
    >> Share

  370. TOMORI S, Morishima S, Nishi Y, Nakachi S, et al
    Transplant-related complications are impediments to the success of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia patients in non-complete remission.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0669.
    >> Share

  371. MA Y, Qu C, Dai H, Yin J, et al
    Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0677.
    >> Share

  372. AMBERGE S, Kramer M, Schrottner P, Heidrich K, et al
    Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0678.
    >> Share

  373. MORRIS C, Chabannon C, Masszi T, Russell N, et al
    Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.
    Bone Marrow Transplant. 2019 Sep 18. pii: 10.1038/s41409-019-0676.
    >> Share

  374. SWEISS K, Lee J, Mahmud N, Calip GS, et al
    Combined immune score of lymphocyte to monocyte ratio and immunoglobulin levels predicts treatment-free survival of multiple myeloma patients after autologous stem cell transplant.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0681.
    >> Share

  375. BENYAMINI N, Lavi N, Zuckerman T, Aviv A, et al
    Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0671.
    >> Share

  376. KOVY P, Meggyesi N, Varga L, Balassa K, et al
    Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 16. pii: 10.1038/s41409-019-0656.
    >> Share

  377. XU J, Zhao R, Yang L, Gong H, et al
    Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2019 Sep 5. pii: 10.1038/s41409-019-0666.
    >> Share

  378. STREILER C, Shaikh F, Davis C, Abhyankar S, et al
    Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease.
    Bone Marrow Transplant. 2019 Sep 4. pii: 10.1038/s41409-019-0662.
    >> Share

  379. FIORENZA S, Routledge D, Collins J, Shipton M, et al
    Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0642.
    >> Share

  380. RAUTENBERG C, Kaivers J, Germing U, Haas R, et al
    Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0664.
    >> Share

    August 2019
  381. VIVAS YAV, Hungria VTM, Costa LJM, Dos Santos KB, et al
    Up-front autologous hematopoietic stem cell transplantation (AHSCT) from a single Brazilian center.
    Bone Marrow Transplant. 2019 Aug 30. pii: 10.1038/s41409-019-0659.
    >> Share

  382. HONG CR, Kang HJ, Moon SJ, Oh J, et al
    Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0655.
    >> Share

  383. TAI J, Buras M, Leis J, Noel P, et al
    Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0648.
    >> Share

  384. FIALA MA, Vosuri V, Goldsmith S, Schroeder MA, et al
    Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0663.
    >> Share

  385. SHOUVAL R, Vega Y, Fein JA, Danylesko I, et al
    Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis.
    Bone Marrow Transplant. 2019 Aug 28. pii: 10.1038/s41409-019-0653.
    >> Share

  386. STYCZYNSKI J, Tridello G, Koster L, Iacobelli S, et al
    Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors.
    Bone Marrow Transplant. 2019 Aug 27. pii: 10.1038/s41409-019-0624.
    >> Share

  387. SANDLER RD, Carter S, Kaur H, Francis S, et al
    Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?
    Bone Marrow Transplant. 2019 Aug 27. pii: 10.1038/s41409-019-0637.
    >> Share

  388. CESARO S, Tridello G, van der Werf S, Bader P, et al
    Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0644.
    >> Share

  389. KORDELAS L, Gorgens A, Radtke S, Horn PA, et al
    Allogeneic transplantation of peripheral blood stem cell grafts results in a massive decrease of primitive hematopoietic progenitor frequencies in reconstituted bone marrows.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0645.
    >> Share

  390. RIVAS MM, Berro M, Prates MV, Yantorno S, et al
    Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0640.
    >> Share

  391. SHICHIJO T, Fuji S, Nagler A, Bazarbachi A, et al
    Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0643.
    >> Share

  392. PACCOUD O, Guitard J, Labopin M, Surgers L, et al
    Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting.
    Bone Marrow Transplant. 2019 Aug 21. pii: 10.1038/s41409-019-0641.
    >> Share

  393. XHAARD A, Launay M, Sicre de Fontbrune F, Michonneau D, et al
    A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor.
    Bone Marrow Transplant. 2019 Aug 14. pii: 10.1038/s41409-019-0633.
    >> Share

  394. BONDEELLE L, Gras J, Michonneau D, Houdouin V, et al
    Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Aug 14. pii: 10.1038/s41409-019-0636.
    >> Share

  395. KERBAUY MN, Mariano L, Seber A, Rocha V, et al
    The impact of low dose busulfan on gonodal function after allogeneic hematopoietic stem cell transplantation for aplastic anemia.
    Bone Marrow Transplant. 2019 Aug 13. pii: 10.1038/s41409-019-0639.
    >> Share

  396. ATOUI A, El Labban M, Ghaoui N, El Darsa H, et al
    Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2019 Aug 12. pii: 10.1038/s41409-019-0635.
    >> Share

  397. SWEISS K, Calip GS, Johnson JJ, Rondelli D, et al
    Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2019 Aug 6. pii: 10.1038/s41409-019-0628.
    >> Share

  398. TAVAKOLI ARDAKANI M, Mehrpooya M, Mehdizadeh M, Beiraghi N, et al
    Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial.
    Bone Marrow Transplant. 2019 Aug 5. pii: 10.1038/s41409-019-0623.
    >> Share

  399. STAFFAS A, van den Brink M
    The intestinal flora is required for post-transplant hematopoiesis in recipients of a hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    >> Share

  400. PREZIOSO L, Manfra I, Bonomini S, Schifano C, et al
    Haploidentical hematopoietic stem cell transplantation in adults using the alphabetaTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells.
    Bone Marrow Transplant. 2019;54.
    >> Share

  401. BACIGALUPO A, Maria Raiola A, Dominietto A, Di Grazia C, et al
    Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients.
    Bone Marrow Transplant. 2019;54.
    >> Share

  402. BIELORAI B, Jacoby E, Varda-Bloom N, Hutt D, et al
    Haploidentical hematopoietic stem cell transplantation with alphabetaTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.
    Bone Marrow Transplant. 2019;54.
    >> Share

  403. SIDLIK-MUSKATEL R, Reisner Y
    Toward safer haploidnetical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    >> Share

  404. MENDT M, Rezvani K, Shpall E
    Mesenchymal stem cell-derived exosomes for clinical use.
    Bone Marrow Transplant. 2019;54.
    >> Share

  405. SCHLEGEL P, Lang AM, Matela M, Horrer A, et al
    Ex vivo expansion of autologous, donor-derived NK-, gammadeltaT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity.
    Bone Marrow Transplant. 2019;54.
    >> Share

  406. SCHLEGEL P, Jung G, Lang AM, Doring M, et al
    ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL.
    Bone Marrow Transplant. 2019;54.
    >> Share

  407. ANDRE I, Simons L, Ma K, Moirangthem RD, et al
    Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
    Bone Marrow Transplant. 2019;54.
    >> Share

  408. OEVERMANN L, Schulte JH, Hundsdorfer P, Hakimeh D, et al
    HLA-haploidentical hematopoietic stem cell transplantation in pediatric patients with hemoglobinopathies: current practice and new approaches.
    Bone Marrow Transplant. 2019;54.
    >> Share

  409. PIERINI A, Ruggeri L, Mancusi A, Carotti A, et al
    T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease.
    Bone Marrow Transplant. 2019;54.
    >> Share

  410. NAGLER A, Ruggeri A
    Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019;54.
    >> Share

  411. LV M, Chang YJ, Huang XJ
    Update of the "Beijing Protocol" haplo-identical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019;54.
    >> Share

    July 2019
  412. TOTANI A, Amin H, Bacchi S, Lewis I, et al
    Vitiligo following stem-cell transplant.
    Bone Marrow Transplant. 2019 Jul 29. pii: 10.1038/s41409-019-0626.
    >> Share

    June 2019
  413. GOMEZ-ARTEAGA A, Mark TM, Guarneri D, Christos PJ, et al
    High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0587.
    >> Share

  414. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2019 Jun 12. pii: 10.1038/s41409-019-0590.
    >> Share

  415. NAKAGAKI M, Button E, Keating A, Marsh J, et al
    Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation.
    Bone Marrow Transplant. 2019 Jun 11. pii: 10.1038/s41409-019-0586.
    >> Share

  416. ZHAO Y, Shi J, Li X, Wang J, et al
    Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2019 Jun 4. pii: 10.1038/s41409-019-0577.
    >> Share

  417. RUUTU T, van der Werf S, van Biezen A, Backman JT, et al
    Use of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2019 Jun 3. pii: 10.1038/s41409-019-0579.
    >> Share

    May 2019
  418. YANO S, Yokoyama H, Yanada M, Mori J, et al
    Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0571.
    >> Share

  419. DIETRICH S, Dreger P, Hermine O, Kyriakou C, et al
    Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0583.
    >> Share

  420. TUCCI F, Frittoli M, Barzaghi F, Calbi V, et al
    Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0573.
    >> Share

  421. RUGGERI A, Labopin M, Savani B, Paviglianiti A, et al
    Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0582.
    >> Share

  422. VIJAYVARGIYA P, Gonsalves W, Burton D, Hogan WJ, et al
    Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant.
    Bone Marrow Transplant. 2019 May 31. pii: 10.1038/s41409-019-0581.
    >> Share

  423. HEUMULLER A, Wehrle J, Stosch J, Niemoller C, et al
    Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors.
    Bone Marrow Transplant. 2019 May 30. pii: 10.1038/s41409-019-0575.
    >> Share

  424. KAITO S, Sekiya N, Najima Y, Suzuki T, et al
    Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 29. pii: 10.1038/s41409-019-0541.
    >> Share

  425. BIRAN N, Rowley SD, Vesole DH, Zhang S, et al
    A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0534.
    >> Share

  426. LANGEBRAKE C, Admiraal R, van Maarseveen E, Bonnin A, et al
    Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 May 17. pii: 10.1038/s41409-019-0538.
    >> Share

  427. IIDA M, Kodera Y, Dodds A, Ho AYL, et al
    Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0554.
    >> Share

  428. BABOR F, Peters C, Manser AR, Glogova E, et al
    Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0543.
    >> Share

  429. AL HAMED R, Bazarbachi AH, Mohty M
    Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0548.
    >> Share

  430. SENN-MALASHONAK A, Wallek S, Schmidt K, Rosenhagen A, et al
    Psychophysical effects of an exercise therapy during pediatric stem cell transplantation: a randomized controlled trial.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0535.
    >> Share

  431. PUNATAR S, Mohite A, Gokarn A, Nayak L, et al
    Leflunomide for chronic musculoskeletal graft versus host disease following allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0545.
    >> Share

  432. GUILLAUME T, Malard F, Magro L, Labopin M, et al
    Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0536.
    >> Share

  433. AXT L, Naumann A, Toennies J, Haen SP, et al
    Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0544.
    >> Share

  434. ESTEVES I, Santos FPS, Fernandes JF, Seber A, et al
    Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0521.
    >> Share

  435. KATOH D, Ochi Y, Hiramoto N, Morita M, et al
    Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0533.
    >> Share

  436. NISHIWAKI S, Miyamura K, Kanda Y, Takanashi M, et al
    A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0542.
    >> Share

  437. CAMPAGNA A, Gianfelici V, Antolino G, Pelliccia S, et al
    Central nervous system immune reconstitution inflammatory syndrome after autologous stem cell transplantation.
    Bone Marrow Transplant. 2019 May 8. pii: 10.1038/s41409-019-0532.
    >> Share

    April 2019
  438. OEVERMANN L, Zimmermann C, Voigt S, Kunkele A, et al
    Transmission of chromosomally integrated human herpes virus-6A via haploidentical stem cell transplantation poses a risk for virus reactivation and associated complications.
    Bone Marrow Transplant. 2019 Apr 15. pii: 10.1038/s41409-019-0530.
    >> Share

  439. YAMASAKI S, Aoki J, Mori J, Mizuno S, et al
    Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0527.
    >> Share

  440. WIENER L, Hoag JA, Pelletier W, Shah NN, et al
    Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors.
    Bone Marrow Transplant. 2019 Apr 10. pii: 10.1038/s41409-019-0515.
    >> Share

  441. SIDIQI MH, Nadiminti K, Al Saleh AS, Meleveedu K, et al
    Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0524.
    >> Share

  442. LUBKING A, Dreimane A, Sandin F, Isaksson C, et al
    Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
    Bone Marrow Transplant. 2019 Apr 8. pii: 10.1038/s41409-019-0513.
    >> Share

  443. DUARTE RF, Labopin M, Bader P, Basak GW, et al
    Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0516.
    >> Share

  444. SOLH MM, Dickhaus E, Solomon SR, Morris LE, et al
    Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0522.
    >> Share

  445. BUHLER S, Baldomero H, Ferrari-Lacraz S, Nunes JM, et al
    High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Apr 5. pii: 10.1038/s41409-019-0520.
    >> Share

    March 2019
  446. DANIEL-MORENO A, Lamsfus-Calle A, Raju J, Antony JS, et al
    CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 22. pii: 10.1038/s41409-019-0510.
    >> Share

  447. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 21. pii: 10.1038/s41409-019-0509.
    >> Share

  448. KISHIMOTO K, Hasegawa D, Kawasaki K, Tamura A, et al
    Early posttransplant plasma ADAMTS13 activity reduction in stem cell transplantation: a prospective study of 46 pediatric patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0506.
    >> Share

  449. GRANATA A, Furst S, Bramanti S, Legrand F, et al
    Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0500.
    >> Share

  450. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Author Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Mar 19. pii: 10.1038/s41409-019-0512.
    >> Share

  451. KIMURA F, Kanda J, Ishiyama K, Yabe T, et al
    ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0496.
    >> Share

  452. LUO Y, Jin M, Tan Y, Zhao Y, et al
    Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 13. pii: 10.1038/s41409-019-0502.
    >> Share

  453. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2019 Mar 12. pii: 10.1038/s41409-019-0504.
    >> Share

  454. HOLDERRIED TAW, Fraccaroli A, Schumacher M, Heine A, et al
    The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0498.
    >> Share

  455. LA ROCCA U, Perrone MP, Piciocchi A, Cinti P, et al
    Anti-HLA donor-specific antibodies in allogeneic stem cell transplantation: management and desensitization protocol.
    Bone Marrow Transplant. 2019 Mar 4. pii: 10.1038/s41409-019-0497.
    >> Share

    February 2019
  456. KARLAS T, Weisse T, Petroff D, Beer S, et al
    Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0464.
    >> Share

  457. BAUMGARTNER A, Moesch M, Zumsteg M, Struja T, et al
    Predictors of impaired bone health in long-term survivors after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0484.
    >> Share

  458. KATO K, Mori T, Kim SW, Sawa M, et al
    Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantati
    Bone Marrow Transplant. 2019 Feb 26. pii: 10.1038/s41409-019-0491.
    >> Share

  459. HUBEL K, Re A, Boumendil A, Finel H, et al
    Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2019 Feb 25. pii: 10.1038/s41409-019-0480.
    >> Share

  460. KOO J, Silverman S, Nuechterlein B, Keating AK, et al
    Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0479.
    >> Share

  461. MIZUNO S, Kawamura K, Hanamura I, Sunami K, et al
    Efficacy and safety of autologous stem cell transplantation in patients aged >/= 65 years with multiple myeloma in the era of novel agents.
    Bone Marrow Transplant. 2019 Feb 19. pii: 10.1038/s41409-019-0478.
    >> Share

  462. FAYARD A, Daguenet E, Blaise D, Chevallier P, et al
    Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem
    Bone Marrow Transplant. 2019 Feb 15. pii: 10.1038/s41409-019-0475.
    >> Share

  463. GABALLA A, Stikvoort A, Onfelt B, Mattsson J, et al
    T-cell frequencies of CD8(+) gammadelta and CD27(+) gammadelta cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2019 Feb 5. pii: 10.1038/s41409-019-0462.
    >> Share

  464. ITONAGA H, Ishiyama K, Aoki K, Aoki J, et al
    Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0469.
    >> Share

  465. JOHANSSON JE, Bratel J, Hardling M, Heikki L, et al
    Cryotherapy as prophylaxis against oral mucositis after high-dose melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0468.
    >> Share

  466. SENGELOV H, Petersen PM, Fog L, Schmidt M, et al
    Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0470.
    >> Share

  467. OKAMOTO Y, Kudo K, Tabuchi K, Tomizawa D, et al
    Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0461.
    >> Share

  468. FARNAULT L, Venton G, Pourroy B, Jourde-Chiche N, et al
    Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0467.
    >> Share

  469. BATTIPAGLIA G, Boumendil A, Labopin M, Ciceri F, et al
    Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0459.
    >> Share

  470. SINGER S, Sharma N, Dean R, Zhao Q, et al
    BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.
    Bone Marrow Transplant. 2019 Feb 4. pii: 10.1038/s41409-019-0463.
    >> Share

  471. ZHANG YY, Mo XD, Zhang XH, Xu LP, et al
    FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients.
    Bone Marrow Transplant. 2019 Feb 1. pii: 10.1038/s41409-019-0456.
    >> Share

    January 2019
  472. JESSOP H, Farge D, Saccardi R, Alexander T, et al
    General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT
    Bone Marrow Transplant. 2019 Jan 31. pii: 10.1038/s41409-019-0430.
    >> Share

  473. BENOIT SW, Dixon BP, Goldstein SL, Bennett MR, et al
    A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 30. pii: 10.1038/s41409-018-0428.
    >> Share

  474. POIREL HA, Vanspauwen M, Macq G, De Geyndt A, et al
    Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0458.
    >> Share

  475. ABIDI MZ, Hari P, Chen M, Kim S, et al
    Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study.
    Bone Marrow Transplant. 2019 Jan 29. pii: 10.1038/s41409-019-0457.
    >> Share

  476. WEN Q, Kong Y, Zhao HY, Zhang YY, et al
    G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 25. pii: 10.1038/s41409-019-0449.
    >> Share

  477. MARIOTTI J, Granata A, Bramanti S, Devillier R, et al
    The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Jan 24. pii: 10.1038/s41409-019-0453.
    >> Share

  478. FUJIWARA SI, Kanda J, Tatara R, Ogawa H, et al
    Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 22. pii: 10.1038/s41409-019-0434.
    >> Share

  479. GUTIERREZ-GARCIA G, Cibeira MT, Rovira M, Fernandez de Larrea C, et al
    Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0447.
    >> Share

  480. PHULL P, Sanchorawala V, Brauneis D, Sloan JM, et al
    High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0440.
    >> Share

  481. FU H, Zhang X, Han T, Mo X, et al
    Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0435.
    >> Share

  482. WIKTOR-JEDRZEJCZAK W, Drozd-Sokolowska J, Eikema DJ, Hoek J, et al
    EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0448.
    >> Share

  483. KE P, Bao X, Qiu H, Zhuang J, et al
    Central nervous system complications caused by 3-4 grade aGVHD in adult patients occurred in HLA-mismatched recipients majorly after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0443.
    >> Share

  484. ABADIR E, Bryant C, Larsen S, Clark GJ, et al
    Targeting the niche: depleting haemopoietic stem cells with targeted therapy.
    Bone Marrow Transplant. 2019 Jan 21. pii: 10.1038/s41409-019-0445.
    >> Share

  485. ADKINS BD, Savani BN, Booth GS
    Transgender individuals represent an overlooked population amongst stem cell donors.
    Bone Marrow Transplant. 2019 Jan 18. pii: 10.1038/s41409-019-0437.
    >> Share

  486. HINO T, Imi T, Hangaishi A, Kamoda Y, et al
    Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.
    Bone Marrow Transplant. 2019 Jan 10. pii: 10.1038/s41409-018-0420.
    >> Share

    December 2018
  487. WANG RC, Mori S, Zhu X, Varela JC, et al
    Increased bone marrow CD56(bright) natural killer cells at 30 days after allogeneic stem cell transplantation associated with adverse patient outcome.
    Bone Marrow Transplant. 2018 Dec 18. pii: 10.1038/s41409-018-0407.
    >> Share

  488. USTUN C, Young JH, Papanicolaou GA, Kim S, et al
    Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Dec 13. pii: 10.1038/s41409-018-0401.
    >> Share

  489. ALATRASH G, Kidwell KM, Thall PF, Di Stasi A, et al
    Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
    Bone Marrow Transplant. 2018 Dec 10. pii: 10.1038/s41409-018-0405.
    >> Share

  490. UMEDA K, Yabe H, Kato K, Imai K, et al
    Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0418.
    >> Share

  491. INAMOTO Y, Valdes-Sanz N, Ogawa Y, Alves M, et al
    Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0340.
    >> Share

  492. BONDANZA A, Ruggeri L, Noviello M, Eikema DJ, et al
    Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting.
    Bone Marrow Transplant. 2018 Dec 7. pii: 10.1038/s41409-018-0351.
    >> Share

  493. ZHAO J, Zu Y, Han L, Zhang Y, et al
    Treatment of Epstein-Barr virus associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation with intrathecal donor lymphocyte infusion.
    Bone Marrow Transplant. 2018 Dec 5. pii: 10.1038/s41409-018-0409.
    >> Share

    November 2018
  494. HIGASHINO HR, Marchi AP, Martins RCR, Batista MV, et al
    Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0416.
    >> Share

  495. BAIER DM, Hofmann JA, Fischer H, Rall G, et al
    Very low error rates of NGS-based HLA typing at stem cell donor recruitment question the need for a standard confirmatory typing step before donor work-up.
    Bone Marrow Transplant. 2018 Nov 30. pii: 10.1038/s41409-018-0411.
    >> Share

  496. JELINEK T, Adamusova L, Popkova T, Tvrda I, et al
    Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
    Bone Marrow Transplant. 2018 Nov 20. pii: 10.1038/s41409-018-0396.
    >> Share

  497. YANG J, Jiang J, Cai Y, Li S, et al
    Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malig
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0382.
    >> Share

  498. GOWDA L, Shah M, Badar I, Bashir Q, et al
    Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0392.
    >> Share

  499. KUMAR A, Reljic T, Hamadani M, Mohty M, et al
    Antithymocyte globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0393.
    >> Share

  500. WULF G, Hasenkamp J, Jung W, Wilhelm C, et al
    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0360.
    >> Share

  501. TROVILLION EM, Gloude NJ, Anderson EJ, Morris GP, et al
    Relationship of post-transplant thymopoiesis with CD4(+)FoxP3(+) regulatory T cell recovery associated with freedom from chronic graft versus host disease.
    Bone Marrow Transplant. 2018 Nov 9. pii: 10.1038/s41409-018-0394.
    >> Share

  502. PAGLIARDINI T, Harbi S, Furst S, Castagna L, et al
    Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0387.
    >> Share

  503. GERULL S, Tschan-Plessl A, Mathew R, Nair G, et al
    Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0376.
    >> Share

  504. ROS-SOTO J, Anthias C, Madrigal A, Snowden JA, et al
    Vitamin D: is it important in haematopoietic stem cell transplantation? A review.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0377.
    >> Share

  505. KNOLL BM, Seiter K, Phillips A, Soave R, et al
    Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0389.
    >> Share

  506. WEBER D, Weber M, Hippe K, Ghimire S, et al
    Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound.
    Bone Marrow Transplant. 2018 Nov 6. pii: 10.1038/s41409-018-0381.
    >> Share

  507. NORMAN JE, Schouten HC, Dreger P, Robinson SP, et al
    The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0372.
    >> Share

  508. GALLANAGH M, Shaw O, Kaur H, Raj K, et al
    Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0384.
    >> Share

  509. GHILARDI G, Pabst T, Jeker B, Muller R, et al
    Melphalan dose in myeloma patients >/=65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0379.
    >> Share

  510. SIDIQI MH, Aljama MA, Muchtar E, Buadi FK, et al
    Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation.
    Bone Marrow Transplant. 2018 Nov 2. pii: 10.1038/s41409-018-0388.
    >> Share

  511. GIEBEL S, Marks DI, Boissel N, Baron F, et al
    Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute L
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0373.
    >> Share

  512. EICHENBERGER EM, Soave R, Zappetti D, Small CB, et al
    Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Nov 1. pii: 10.1038/s41409-018-0386.
    >> Share

    October 2018
  513. PATEL SS, Rybicki LA, Corrigan D, Dumont C, et al
    Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Oct 30. pii: 10.1038/s41409-018-0380.
    >> Share

  514. RIVERA D, Bastida JM, Lopez-Corral L, Sanchez-Guijo F, et al
    Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0368.
    >> Share

  515. DANYLESKO I, Bukauskas A, Paulson M, Peceliunas V, et al
    Anti-alpha4beta7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 24. pii: 10.1038/s41409-018-0364.
    >> Share

  516. KAROW A, Wilhelm A, Ammann RA, Baerlocher GM, et al
    Peripheral blood progenitor cell collection in pediatric patients optimized by high pre-apheresis count of circulating CD34+ cells and high blood flow.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0353.
    >> Share

  517. HARASHIMA S, Yoneda R, Horie T, Fujioka Y, et al
    Psychosocial Assessment of Candidates for Transplantation scale (PACT) and survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 23. pii: 10.1038/s41409-018-0371.
    >> Share

  518. JABBOUR J, Manana B, Sakr M, Zahreddine A, et al
    The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial.
    Bone Marrow Transplant. 2018 Oct 22. pii: 10.1038/s41409-018-0366.
    >> Share

  519. ZIEGLER AK, Abend M, Port M, Dammann E, et al
    Cumulative dosages of chemotherapy and radiotherapy exposure, and risk of secondary malignancies after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0359.
    >> Share

  520. SHAH MV, Saliba RM, Rondon G, Chen J, et al
    Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0367.
    >> Share

  521. HAYAKAWA J, Miyamura D, Kimura SI, Gomyo A, et al
    Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0365.
    >> Share

  522. KALOYANNIDIS P, Shaibani EA, Apostolidis I, Kanfar S, et al
    Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Oct 18. pii: 10.1038/s41409-018-0362.
    >> Share

  523. DE LA HOZ A, Foolad F, Gallegos C, Kornblau S, et al
    Nivolumab-induced encephalitis post allogeneic stem cell transplant in a patient with Hodgkin's disease.
    Bone Marrow Transplant. 2018 Oct 15. pii: 10.1038/s41409-018-0363.
    >> Share

  524. KUROSAWA S, Yamaguchi T, Oshima K, Yanagisawa A, et al
    Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0343.
    >> Share

  525. BAE SK, Gushima T, Saito N, Yamanaka I, et al
    HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0355.
    >> Share

  526. MOUKALLED NM, El Darsa H, Haibe Y, Massoud R, et al
    Feasibility of Venetoclax-based combinations for adult patients with acute myeloid leukemia relapsing after allogenic stem cell transplantation.
    Bone Marrow Transplant. 2018 Oct 4. pii: 10.1038/s41409-018-0347.
    >> Share

  527. PAHNKE S, Egeland T, Halter J, Hagglund H, et al
    Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0350.
    >> Share

  528. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    >> Share

  529. PINGEL J, Wang T, Hagenlocher Y, Hernandez-Frederick CJ, et al
    The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
    Bone Marrow Transplant. 2018 Oct 2. pii: 10.1038/s41409-018-0345.
    >> Share

    September 2018
  530. SMELAND KB, Loge JH, Aass HCD, Aspelin T, et al
    Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity.
    Bone Marrow Transplant. 2018 Sep 27. pii: 10.1038/s41409-018-0342.
    >> Share

  531. JAIME-PEREZ JC, Salazar-Cavazos L, Aguilar-Calderon P, Herrera-Garza JL, et al
    Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country.
    Bone Marrow Transplant. 2018 Sep 21. pii: 10.1038/s41409-018-0338.
    >> Share

  532. SALEEM MS, Aljurf M, Srivastava A, Shamsi T, et al
    Challenges in managing graft-versus-host disease in developing countries: a perspective.
    Bone Marrow Transplant. 2018 Sep 20. pii: 10.1038/s41409-018-0333.
    >> Share

  533. BONIFAZI F, Dan E, Labopin M, Sessa M, et al
    Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
    Bone Marrow Transplant. 2018 Sep 19. pii: 10.1038/s41409-018-0335.
    >> Share

  534. NAFTULIN JS, Penzi LR, Manatis-Lornell A, Yasuda MR, et al
    Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults.
    Bone Marrow Transplant. 2018 Sep 13. pii: 10.1038/s41409-018-0309.
    >> Share

    August 2018
  535. KAMEDA K, Kimura SI, Misaki Y, Yoshimura K, et al
    Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0330.
    >> Share

  536. TSANG ES, Villa D, Loscocco F, Visani G, et al
    High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 31. pii: 10.1038/s41409-018-0328.
    >> Share

  537. LIN RJ, Elko TA, Perales MA, Alexander K, et al
    End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0311.
    >> Share

  538. MOHANAN E, Panetta JC, Lakshmi KM, Edison ES, et al
    Correction: Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 22. pii: 10.1038/s41409-018-0276.
    >> Share

  539. CHAULAGAIN CP, Sprague KA, Pilichowska M, Cowan J, et al
    Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0299.
    >> Share

  540. YAKUSHIJIN K, Ikezoe T, Ohwada C, Kudo K, et al
    Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 20. pii: 10.1038/s41409-018-0304.
    >> Share

  541. KANELLOPOULOS A, Kaparou M, Xenou E, Paneesha S, et al
    Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0297.
    >> Share

  542. LADETTO M, Bottcher S, Kroger N, Pulsipher MA, et al
    Methods and role of minimal residual disease after stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0307.
    >> Share

  543. PICCALUGA PP, Rapezzi D, Gazzola A, Malagola M, et al
    Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0268.
    >> Share

  544. MILLER KC, Gertz MA, Buadi FK, Hayman SR, et al
    Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0302.
    >> Share

  545. GUNES G, Goker H, Demiroglu H, Malkan UY, et al
    Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors.
    Bone Marrow Transplant. 2018 Aug 16. pii: 10.1038/s41409-018-0303.
    >> Share

  546. MATSUDA K, Honda A, Arai S, Maki H, et al
    Retrospective analysis on transient recurrence of steroid-sensitive acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0274.
    >> Share

  547. DABAS R, Dharmani-Khan P, Modi M, Van Slyke T, et al
    Anti-thymocyte globulin's activity against acute myeloid leukemia stem cells.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0296.
    >> Share

  548. BITTENCOURT MCB, Mariano L, Moreira F, Schmidt-Filho J, et al
    Cryopreserved versus non-cryopreserved peripheral blood stem cells for autologous transplantation after high-dose Melphalan in multiple myeloma: comparative analysis.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0250.
    >> Share

  549. KRAFT S, Bollinger N, Bodenmann B, Heim D, et al
    High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0293.
    >> Share

  550. PHILIPPE M, Neely M, Rushing T, Bertrand Y, et al
    Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children.
    Bone Marrow Transplant. 2018 Aug 14. pii: 10.1038/s41409-018-0281.
    >> Share

  551. MARTELIN E, Volin L, Itala-Remes M, Niittyvuopio R, et al
    Incidence and risk factors of secondary cancers after allogeneic stem cell transplantation: analysis of a single centre cohort with a long follow-up.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0290.
    >> Share

  552. DOUCETTE K, Tian X, Chawla U, Jain NA, et al
    Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0282.
    >> Share

  553. PHILLIPS EH, Lannon MM, Lopes A, Chadwick H, et al
    High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
    Bone Marrow Transplant. 2018 Aug 13. pii: 10.1038/s41409-018-0294.
    >> Share

  554. VARGA C, Comenzo RL
    High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0284.
    >> Share

  555. KEREP AZ, Broome J, Pirsl F, Curtis LM, et al
    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0224.
    >> Share

  556. PERIC Z, Skegro I, Durakovic N, Desnica L, et al
    Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease.
    Bone Marrow Transplant. 2018 Aug 8. pii: 10.1038/s41409-018-0140.
    >> Share

  557. MUKHERJEE A, Ekinci E, Scholoff A, Obi G, et al
    Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0285.
    >> Share

  558. KONISHI Y, Kondo T, Nakao K, Asagoe K, et al
    Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0287.
    >> Share

  559. SUGITA J, Kagaya Y, Miyamoto T, Shibasaki Y, et al
    Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Aug 7. pii: 10.1038/s41409-018-0279.
    >> Share

  560. BALDOMERO H, Aljurf M, Zaidi SZA, Hashmi SK, et al
    Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0275.
    >> Share

  561. VAN DER HEIDEN PLJ, Arbous MS, van Beers EJ, van den Bergh WM, et al
    Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Aug 6. pii: 10.1038/s41409-018-0277.
    >> Share

    July 2018
  562. HIRANO M, Jimbo K, Ogawa M, Ochi K, et al
    Chronic inflammatory demyelinating polyneuropathy in adult T-cell leukemia-lymphoma patients following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0202.
    >> Share

  563. SAITO A, Nishikawa T, Oyoshi T, Nakagawa S, et al
    Giant radiation-induced cavernous haemangioma before reduced-intensity bone marrow transplantation for acute lymphoblastic leukaemia.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0272.
    >> Share

  564. CHEN YB, McCarthy PL, Hahn T, Holstein SA, et al
    Methods to prevent and treat relapse after hematopoietic stem cell transplantation with tyrosine kinase inhibitors, immunomodulating drugs, deacetylase inhibitors, and hypomethylating agents.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0269.
    >> Share

  565. BHUTANI D, Jaiyeoba C, Kim S, Naylor P, et al
    Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0270.
    >> Share

  566. HAGEN PA, Adams W, Smith S, Tsai S, et al
    Low mean post-transplantation tacrolimus levels in weeks 2-3 correlate with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation from related and unrelated donors.
    Bone Marrow Transplant. 2018 Jul 23. pii: 10.1038/s41409-018-0267.
    >> Share

  567. TAY J, Daly A, Jamani K, Labelle L, et al
    Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0265.
    >> Share

  568. GONSALVES WI, Buadi FK, Ailawadhi S, Bergsagel PL, et al
    Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0264.
    >> Share

  569. YANG B, Yu R, Cai L, Bin Guo, et al
    Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis.
    Bone Marrow Transplant. 2018 Jul 9. pii: 10.1038/s41409-018-0239.
    >> Share

    June 2018
  570. TOMIZAWA D, Yoshida M, Kondo T, Miyamura T, et al
    Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
    Bone Marrow Transplant. 2018 Jun 29. pii: 10.1038/s41409-018-0273.
    >> Share

  571. TANG S, Shen H, Qu C, Dai H, et al
    Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 25. pii: 10.1038/s41409-018-0249.
    >> Share

  572. CHUNG H, Hong KT, Lee JW, Rhee SJ, et al
    Pharmacokinetics of fludarabine and its association with clinical outcomes in paediatric haematopoietic stem cell transplantation patients.
    Bone Marrow Transplant. 2018 Jun 18. pii: 10.1038/s41409-018-0260.
    >> Share

  573. HARI P, Reece DE, Randhawa J, Flomenberg N, et al
    Final outcomes of escalated melphalan 280 mg/m(2) with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0261.
    >> Share

  574. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches.
    Bone Marrow Transplant. 2018 Jun 15. pii: 10.1038/s41409-018-0262.
    >> Share

  575. MALARD F, Gasc C, Plantamura E, Dore J, et al
    High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0254.
    >> Share

  576. WONG E, Davis JE, Grigg A, Szer J, et al
    Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 14. pii: 10.1038/s41409-018-0244.
    >> Share

  577. SOLANO C, Gimenez E, Albert E, Mateo EM, et al
    Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0251.
    >> Share

  578. GABELLI M, Zecca M, Messina C, Carraro E, et al
    Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children.
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0259.
    >> Share

  579. HOCHBERG J, Zahler S, Geyer MB, Chen N, et al
    The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leuke
    Bone Marrow Transplant. 2018 Jun 13. pii: 10.1038/s41409-018-0247.
    >> Share

  580. NADEMI Z, Wynn RF, Slatter M, Hughes SM, et al
    Hematopoietic stem cell transplantation for cytidine triphosphate synthase 1 (CTPS1) deficiency.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0246.
    >> Share

  581. MOOR I, Bacher VU, Jeker B, Taleghani BM, et al
    Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0245.
    >> Share

  582. DOESCHER A, Casper J, Kraemer D, Kapels HH, et al
    Digital PCR to assess platelet recovery after stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0238.
    >> Share

  583. WHITE PS, Phull P, Brauneis D, Sloan JM, et al
    High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0242.
    >> Share

  584. AL-SAUD B, Al-Jomaie M, Al-Ghonaium A, Al-Ahmari A, et al
    Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0219.
    >> Share

  585. GRIFFIN SP, Wheeler SE, Wiggins LE, Murthy HS, et al
    Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0240.
    >> Share

  586. ROBINSON SP, Boumendil A, Finel H, Dreger P, et al
    High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0196.
    >> Share

  587. SORENSEN CD, Moller BK, Olesen G, Hokland P, et al
    Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jun 8. pii: 10.1038/s41409-018-0229.
    >> Share

  588. SCHOEMANS HM, Lee SJ, Ferrara JL, Wolff D, et al
    EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
    Bone Marrow Transplant. 2018 Jun 5. pii: 10.1038/s41409-018-0204.
    >> Share

    May 2018
  589. BURT RK, Han X, Gozdziak P, Yaung K, et al
    Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
    Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0173.
    >> Share

  590. MA CKK, Garcia-Cadenas I, Fox ML, Ai S, et al
    Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0215.
    >> Share

  591. SUREDA A, Dreger P, Bishop MR, Kroger N, et al
    Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0214.
    >> Share

  592. JAIN T, Kunze KL, Temkit M, Partain DK, et al
    Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0226.
    >> Share

  593. GANETSKY A, Frey NV, Hexner EO, Loren AW, et al
    Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0236.
    >> Share

  594. KATO M, Kurata M, Kanda J, Kato K, et al
    Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
    >> Share

  595. GOKBUGET N, Canaani J, Nagler A, Bishop M, et al
    Prevention and treatment of relapse after stem cell transplantation with immunotherapy.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0232.
    >> Share

  596. FALKENBURG F, Ruggiero E, Bonini C, Porter D, et al
    Prevention and treatment of relapse after stem cell transplantation by cellular therapies.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0227.
    >> Share

  597. PHAN TL, Pritchett JC, Leifer C, Zerr DM, et al
    HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0225.
    >> Share

  598. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0223.
    >> Share

  599. MANJAPPA S, Fiala MA, King J, Kohnen DA, et al
    The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0216.
    >> Share

  600. JACOBSE J, Mensink H, van der Stoep-Yap MYEC, Kollen WJW, et al
    Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0231.
    >> Share

  601. DAMLAJ M, Alaskar A, Ghazi S, Alahmari B, et al
    Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective.
    Bone Marrow Transplant. 2018 May 9. pii: 10.1038/s41409-018-0208.
    >> Share

  602. TKACZYK ER, Chen F, Wang J, Gandelman JS, et al
    Overcoming human disagreement assessing erythematous lesion severity on 3D photos of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0211.
    >> Share

  603. SATO T, Seto A, Kagaya Y, Kawashima N, et al
    Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0197.
    >> Share

  604. NYGAARD M, Karlsmark T, Andersen NS, Schjodt IM, et al
    Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease.
    Bone Marrow Transplant. 2018 May 8. pii: 10.1038/s41409-018-0206.
    >> Share

  605. TAGEJA N, Korde N, Kazandjian D, Panch S, et al
    Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0170.
    >> Share

  606. KONUMA T, Kohara C, Watanabe E, Mizukami M, et al
    Circulating monocyte subsets in human chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0187.
    >> Share

  607. SAAD A, Taneja A, Di Stasi A, Sarmad R, et al
    Impact of high-dose steroid premedication on the outcome of myeloablative T-cell replete haploidentical peripheral blood stem cell transplant.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0185.
    >> Share

  608. ASLAM HM, Yousuf S, Kassim A, Iqbal SM, et al
    Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0193.
    >> Share

  609. CHEN Y, Xu LP, Zhang XH, Chen H, et al
    Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.
    Bone Marrow Transplant. 2018 May 3. pii: 10.1038/s41409-018-0175.
    >> Share

  610. SELLMANN L, Rabe K, Bunting I, Dammann E, et al
    Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2018 May 2. pii: 10.1038/s41409-018-0176.
    >> Share

    April 2018
  611. YANG L, Tan Y, Shi J, Zhao Y, et al
    Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
    Bone Marrow Transplant. 2018 Apr 30. pii: 10.1038/s41409-018-0184.
    >> Share

  612. GUTIERREZ-GARCIA G, Rovira M, Magnano L, Rosinol L, et al
    Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 29. pii: 10.1038/s41409-018-0189.
    >> Share

  613. PRESTES DP, Mendes C, Batista MV, Ramos JF, et al
    A case-series of Toxoplasmosis in hematopoietic stem cell transplantation: still a concern for endemic countries.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0179.
    >> Share

  614. AERTS-KAYA F, Koca G, Sharafi P, Sayla FC, et al
    Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0192.
    >> Share

  615. NOGUCHI M, Moritake H, Kamimura S, Sonoda M, et al
    Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.
    Bone Marrow Transplant. 2018 Apr 27. pii: 10.1038/s41409-018-0180.
    >> Share

  616. SOLANO C, Talaya A, Gimenez E, Albert E, et al
    Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0191.
    >> Share

  617. BROWNBACK KR, Pitts LR, Abhyankar S
    Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 26. pii: 10.1038/s41409-018-0182.
    >> Share

  618. JODELE S, Dandoy CE, Myers K, Wallace G, et al
    High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.
    Bone Marrow Transplant. 2018 Apr 19. pii: 10.1038/s41409-018-0159.
    >> Share

  619. HOROWITZ M, Schreiber H, Elder A, Heidenreich O, et al
    Epidemiology and biology of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0171.
    >> Share

  620. PEREZ L, Fernandez H, Horna P, Riches M, et al
    Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Apr 18. pii: 10.1038/s41409-018-0163.
    >> Share

  621. GRECO R, Ciceri F, Noviello M, Bondanza A, et al
    Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.
    Bone Marrow Transplant. 2018 Apr 17. pii: 10.1038/s41409-018-0167.
    >> Share

  622. PERIC Z, Wilson J, Durakovic N, Ostojic A, et al
    Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0172.
    >> Share

  623. BATTIPAGLIA G, Ruggeri A, Labopin M, Volin L, et al
    Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Apr 16. pii: 10.1038/s41409-018-0169.
    >> Share

    March 2018
  624. NAITHANI R, Dayal N, Pathak S, Rai R, et al
    Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma.
    Bone Marrow Transplant. 2018 Mar 29. pii: 10.1038/s41409-018-0174.
    >> Share

  625. CASTAGNOLA E, Bagnasco F, Menoni S, Muraca M, et al
    Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GIT
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0160.
    >> Share

  626. YAHNG SA, Park SS, Jeon YW, Yoon JH, et al
    Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2018 Mar 21. pii: 10.1038/s41409-018-0154.
    >> Share

  627. GAAFAR A, Sheereen A, Almohareb F, Eldali A, et al
    Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0123.
    >> Share

  628. VAN DER WAGEN L, Te Boome L, Schiffler M, Nijhof I, et al
    Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib.
    Bone Marrow Transplant. 2018 Mar 16. pii: 10.1038/s41409-018-0158.
    >> Share

  629. GASSAS A, Sivaprakasam P, Cummins M, Breslin P, et al
    High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0157.
    >> Share

  630. BENEVENTI F, Locatelli E, Simonetta M, Cavagnoli C, et al
    Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0149.
    >> Share

  631. SCHMIDT V, Niederwieser D, Schenk T, Behre G, et al
    Efficacy and safety of keratinocyte growth factor (palifermin) for prevention of oral mucositis in TBI-based allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 15. pii: 10.1038/s41409-018-0135.
    >> Share

  632. KORDELAS L, da Silva Nardi F, Wagner B, Ditschkowski M, et al
    Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 14. pii: 10.1038/s41409-018-0145.
    >> Share

  633. RICHARDS S, Choo S, Mechinaud F, Cole T, et al
    Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2018 Mar 13. pii: 10.1038/s41409-018-0125.
    >> Share

  634. CHUA CC, Lim HY, Chai KL, Ong J, et al
    Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0152.
    >> Share

  635. TROEGER H, Hering NA, Bojarski C, Fromm A, et al
    Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0144.
    >> Share

  636. DEBALS-GONTHIER M, Siani C, Faucher C, Touzani R, et al
    Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years.
    Bone Marrow Transplant. 2018 Mar 9. pii: 10.1038/s41409-018-0133.
    >> Share

  637. LAMB LS, Pillai S, Langford S, Bowersock J, et al
    Clinical-scale manufacturing of gammadelta T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0130.
    >> Share

  638. PERIC Z, Botti S, Stringer J, Krawczyk J, et al
    Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0137.
    >> Share

  639. CHENG Z, Zhou L, Hu K, Dai Y, et al
    Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Mar 7. pii: 10.1038/s41409-018-0146.
    >> Share

    February 2018
  640. GJAERDE LK, Schmidt M, Sengelov H
    Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Feb 28. pii: 10.1038/s41409-018-0131.
    >> Share

  641. AVIVI I, Boumendil A, Finel H, Nagler A, et al
    Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-017-0063.
    >> Share

  642. BUBALO J, Mulverhill K, Meyers G, Hayes-Lattin B, et al
    A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoie
    Bone Marrow Transplant. 2018 Feb 20. pii: 10.1038/s41409-018-0106.
    >> Share

  643. SARMIENTO M, Ramirez P, Parody R, Salas MQ, et al
    Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0117.
    >> Share

  644. MARCHESI F, Capria S, Giannarelli D, Trisolini SM, et al
    BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 13. pii: 10.1038/s41409-018-0120.
    >> Share

  645. WATTS MJ, Ings SJ, Dorman J, Rabin N, et al
    Use of split peripheral blood stem cell harvests in myeloma identifies functional preservation of progenitor cells cryopreserved for several years and demonstrates no functional damage to the bone marrow microenvironment.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0121.
    >> Share

  646. HSU YT, Tsai HJ, Chang JS, Li SS, et al
    Stem cell transplantation for T-cell lymphomas in Taiwan.
    Bone Marrow Transplant. 2018 Feb 12. pii: 10.1038/s41409-018-0116.
    >> Share

  647. BORCHERT-MORLINS B, Memaran N, Sauer M, Maecker-Kolhoff B, et al
    Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age.
    Bone Marrow Transplant. 2018 Feb 9. pii: 10.1038/s41409-018-0104.
    >> Share

  648. MASHEGU H, Smith L, Li Y, Seif A, et al
    The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0113.
    >> Share

  649. TETU P, Jachiet M, de Masson A, Hurabielle C, et al
    Chronic graft versus host disease presenting as lichen planus pigmentosus.
    Bone Marrow Transplant. 2018 Feb 6. pii: 10.1038/s41409-018-0110.
    >> Share

  650. OZDOGU H, Boga C, Yeral M, Kozanoglu I, et al
    Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0111.
    >> Share

  651. YOO KH, Kang D, Kim IR, Choi EK, et al
    Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.
    Bone Marrow Transplant. 2018 Feb 5. pii: 10.1038/s41409-018-0097.
    >> Share

  652. ZHANG Q, Zhou Y, Majaw JK, Xu J, et al
    Acute appendicitis in leukaemia patients undergoing haematopoietic stem cell transplantation during the neutropaenic phase: a case series from a single BMT centre in China.
    Bone Marrow Transplant. 2018;53:219-222.
    >> Share

  653. NYGAARD M, Andersen NS, Moser CE, Olesen G, et al
    Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival.
    Bone Marrow Transplant. 2018 Feb 1. pii: 10.1038/s41409-018-0099.
    >> Share

    January 2018
  654. PATHAK M, Diep PP, Lai X, Brinch L, et al
    Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0090.
    >> Share

  655. TURCOTTE LM, Wang T, Hemmer MT, Spellman SR, et al
    Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
    Bone Marrow Transplant. 2018 Jan 30. pii: 10.1038/s41409-018-0100.
    >> Share

  656. BADER P, Kuci Z, Bakhtiar S, Basu O, et al
    Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-018-0102.
    >> Share

  657. APITHY MJ, Charbonnier A, Desoutter J, Diouf M, et al
    Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0083.
    >> Share

  658. CALBI V, Fumagalli F, Consiglieri G, Penati R, et al
    Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy.
    Bone Marrow Transplant. 2018 Jan 29. pii: 10.1038/s41409-017-0085.
    >> Share

  659. FUJI S, Kurosawa S, Inamoto Y, Murata T, et al
    Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-017-0082.
    >> Share

  660. COLTOFF A, Lancman G, Kim S, Steinberg A, et al
    Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0094.
    >> Share

  661. ALHASHIM N, Aljurf M, Hassanein M, Chaudhri N, et al
    Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0093.
    >> Share

  662. MOHAMMED J, Akomolafe T, Aljurf M, Savani B, et al
    'To treat or not to treat': raising awareness on the effects of graft versus host disease drugs on musculoskeletal system.
    Bone Marrow Transplant. 2018 Jan 25. pii: 10.1038/s41409-018-0095.
    >> Share

  663. WOLFF D, Greinix H, Lee SJ, Gooley T, et al
    Biomarkers in chronic graft-versus-host disease: quo vadis?
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0092.
    >> Share

  664. VAN DEN BRINK M, Uhrberg M, Jahn L, DiPersio JF, et al
    Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0078.
    >> Share

  665. KOTCHETKOV R, Dyszkiewicz-Korpanty A, Kukreti V
    Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0080.
    >> Share

  666. SAITO H, Ito M, Kato S, Kodera Y, et al
    The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0084.
    >> Share

  667. MERKER M, Meister MT, Rettinger E, Jarisch A, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-018-0088.
    >> Share

  668. KHOURY HJ, Langston AA, Kota VK, Wilkinson JA, et al
    Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 24. pii: 10.1038/s41409-017-0081.
    >> Share

  669. JIMENEZ-UBIETO A, Grande C, Caballero D, Yanez L, et al
    Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-018-0096.
    >> Share

  670. ROBERT S, Albring JC, Frebel K, Opitz C, et al
    Alloantigen expression on malignant cells and healthy host tissue influences graft-versus-tumor reactions after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 23. pii: 10.1038/s41409-017-0071.
    >> Share

  671. LAHOUD OB, Moskowitz AJ, Horwitz SM, Giralt SA, et al
    Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-017-0086.
    >> Share

  672. DIEP PP, Melberg HO, Brinch L, Buechner J, et al
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway.
    Bone Marrow Transplant. 2018 Jan 22. pii: 10.1038/s41409-018-0091.
    >> Share

  673. MOHAMMED J, AlGhamdi A, Hashmi SK
    Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease.
    Bone Marrow Transplant. 2018 Jan 18. pii: 10.1038/s41409-017-0075.
    >> Share

  674. FRANGOUL H, Evans M, Isbell J, Bruce K, et al
    Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0077.
    >> Share

  675. BAYDOUN M, Barton DL
    Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review.
    Bone Marrow Transplant. 2018 Jan 16. pii: 10.1038/s41409-017-0073.
    >> Share

  676. ROBINSON SP, Boumendil A, Finel H, Peggs KS, et al
    Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0067.
    >> Share

  677. HUO MR, Pei XY, Li D, Chang YJ, et al
    Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0072.
    >> Share

  678. CALORE E, Marzollo A, Cananzi M, Pizzi M, et al
    Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0065.
    >> Share

  679. SCHUMACHER H, Stuwe S, Kropp P, Diedrich D, et al
    A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0070.
    >> Share

  680. REDDIVALLA N, Robinson AL, Reid KJ, Radhi MA, et al
    Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0064.
    >> Share

  681. SHICHIJO T, Fuji S, Tajima K, Kubo H, et al
    Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0045.
    >> Share

  682. WALLACE G, Myers KC, Teusink-Cross A, Davies SM, et al
    Topical vitamin D analog for chronic graft versus host disease of the skin.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0031.
    >> Share

  683. SCHMALBROCK LK, Bonifacio L, Bill M, Jentzsch M, et al
    Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 15. pii: 10.1038/s41409-017-0060.
    >> Share

  684. GAUTHIER J, Poire X, Gac AC, Leclerc M, et al
    Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0018.
    >> Share

  685. KATZ MC, Michaelis S, Siegmund DM, Koch R, et al
    Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0059.
    >> Share

  686. FERREIRA AM, Pontes da Silva CA, Pereira AD, Szor RS, et al
    Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0068.
    >> Share

  687. HAYASHI H, Ruggeri A, Volt F, Cornelissen JJ, et al
    Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0061.
    >> Share

  688. JONES L, Dandoy C, Jodele S, Myers KC, et al
    Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0041.
    >> Share

  689. LIU Y, Xu L, Zhang X, Wang Y, et al
    Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0030.
    >> Share

  690. CHEN Y, Lu J, Xu LP, Chen H, et al
    Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0069.
    >> Share

  691. OLIVIERI J, Attolico I, Nuccorini R, Pascale SP, et al
    Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0051.
    >> Share

  692. OGAWA H, Ikegame K, Daimon T, Uchida N, et al
    Impact of pretransplant leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0028.
    >> Share

  693. FERNANDES JF, Bonfim C, Kerbauy FR, Rodrigues M, et al
    Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0015.
    >> Share

  694. DEVILLIER R, Labopin M, Chevallier P, Ledoux MP, et al
    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Ma
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0043.
    >> Share

  695. SCHOEMANS HM, Goris K, Van Durm R, Vanbrabant K, et al
    Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0017.
    >> Share

  696. MAYER K, Schumacher M, Eis-Hubinger AM, Pietzonka S, et al
    Intravesical cidofovir application in BK virus cystitis after allogeneic hematopoetic stem cell transplantation (HSCT) is safe and highly effective.
    Bone Marrow Transplant. 2018 Jan 12. pii: 10.1038/s41409-017-0044.
    >> Share

    December 2017
  697. JUDET A, Copie-Bergman C, Zemoura L, Catherinot E, et al
    Epithelial chimerism in lung tissue after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0050.
    >> Share

  698. FALCONE U, Jiang H, Bashir S, Tsang R, et al
    Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0054.
    >> Share

  699. DEOTARE U, Atenafu EG, Loach D, Michelis FV, et al
    Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0053.
    >> Share

  700. MITRUS I, Smagur A, Fidyk W, Czech M, et al
    Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0056.
    >> Share

  701. SEE WQ, Tung JY, Cheuk DK, Hwang YY, et al
    Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0052.
    >> Share

  702. KUSKONMAZ B, Ayvaz D, Tezcan I, Yuce A, et al
    Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0040.
    >> Share

  703. DIROU S, Chambellan A, Chevallier P, Germaud P, et al
    Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0057.
    >> Share

  704. LOPEZ-INIGUEZ A, Carrera-Villanueva KA, Leon-Rodriguez E, Cuellar-Rodriguez J, et al
    Recurrent arthritis and immune reconstitution inflammatory syndrome in hematopoietic stem cell transplantation (HSCT).
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0058.
    >> Share

  705. RAGON BK, Mehta RS, Gulbis AM, Saliba RM, et al
    Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0034.
    >> Share

  706. SWEISS K, Anderson J, Wirth S, Oh A, et al
    A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0024.
    >> Share

  707. SIDANA S, Tandon N, Gertz MA, Dispenzieri A, et al
    Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0020.
    >> Share

  708. NGUYEN VP, Brauneis D, Kaku M, Sloan JM, et al
    Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Bone Marrow Transplant. 2017 Dec 21. pii: 10.1038/s41409-017-0048.
    >> Share

  709. VAN GORKOM G, van Gelder M, Eikema DJ, Blok HJ, et al
    Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.
    Bone Marrow Transplant. 2017 Dec 18. pii: 10.1038/s41409-017-0023.
    >> Share

  710. UHM J, Shin E, Michelis FV, Thyagu S, et al
    Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
    Bone Marrow Transplant. 2017 Dec 15. pii: 10.1038/s41409-017-0025.
    >> Share

    November 2017
  711. LEHRER J, Brissot E, Ruggeri A, Dulery R, et al
    Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study.
    Bone Marrow Transplant. 2017 Nov 20. doi: 10.1038/bmt.2017.
    >> Share

  712. FAROWSKI F, Bucker V, Vehreschild JJ, Biehl L, et al
    Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    >> Share

  713. CROCCHIOLO R, Ringden O, Bay JO, Blaise D, et al
    Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    >> Share

  714. CHAKRABORTY R, Muchtar E, Kumar SK, Buadi FK, et al
    Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    >> Share

  715. DOWLING MR, Li S, Dey BR, McAfee SL, et al
    Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Bone Marrow Transplant. 2017 Nov 13. doi: 10.1038/bmt.2017.
    >> Share

    October 2017
  716. ALBERT E, Solano C, Gimenez E, Focosi D, et al
    The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    >> Share

  717. SIVARAJ D, Bacon W, Long GD, Rizzieri DA, et al
    High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    >> Share

  718. SHIN DY, Lee JH, Park S, Lee JO, et al
    Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies.
    Bone Marrow Transplant. 2017 Oct 30. doi: 10.1038/bmt.2017.
    >> Share

  719. JEKER B, Novak U, Mansouri Taleghani B, Baerlocher GM, et al
    NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    >> Share

  720. O'DWYER DN, Duvall AS, Xia M, Hoffman TC, et al
    Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 23. doi: 10.1038/bmt.2017.
    >> Share

  721. SHANIS D, Anandi P, Grant C, Bachi A, et al
    Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  722. MICHNIACKI TF, Mulcahy Levy JM, Quinones RR, Giller RH, et al
    Successful correction of familial hemophagocytic lymphohistiocytosis using prenatal genetic testing and preemptive hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  723. JOFFE E, Rosenberg D, Rozovski U, Perry C, et al
    Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  724. KANSAGRA A, Inwards DJ, Ansell SM, Micallef IN, et al
    Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  725. GOLDSMITH SR, Slade M, DiPersio JF, Westervelt P, et al
    Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  726. FOUZIA NA, Edison ES, Lakshmi KM, Korula A, et al
    Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.
    Bone Marrow Transplant. 2017 Oct 16. doi: 10.1038/bmt.2017.
    >> Share

  727. HEMMATI PG, Pfeifer K, Vuong LG, Jehn CF, et al
    Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  728. YOSHIMURA K, Yano I, Yamamoto T, Kawanishi M, et al
    Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  729. GERULL S, Denhaerynck K, Chalandon Y, Halter JP, et al
    Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  730. CHO C, Hsu M, Barba P, Maloy MA, et al
    Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  731. RE A, Gini G, Rupolo M, Levis A, et al
    Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  732. KROGER N, Bishop M, Giralt S, Wayne A, et al
    Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 9. doi: 10.1038/bmt.2017.
    >> Share

  733. KHOSLA J, Yeh AC, Spitzer TR, Dey BR, et al
    Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    >> Share

  734. GALIENI P, Troiani E, Bigazzi C, Mazzotta S, et al
    Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    >> Share

  735. LIU C, Frank DN, Horch M, Chau S, et al
    Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
    Bone Marrow Transplant. 2017 Oct 2. doi: 10.1038/bmt.2017.
    >> Share

    September 2017
  736. MONTEFUSCO V, Mussetti A, Rezzonico F, Maura F, et al
    Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    >> Share

  737. ALMICI C, Skert C, Bruno B, Bianchetti A, et al
    Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    >> Share

  738. SCHEID C, de Wreede L, van Biezen A, Koenecke C, et al
    Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    >> Share

  739. KUBA K, Esser P, Mehnert A, Johansen C, et al
    Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.
    Bone Marrow Transplant. 2017 Sep 11. doi: 10.1038/bmt.2017.
    >> Share

    May 2017
  740. MALLHI K, Orchard PJ, Miller WP, Cao Q, et al
    Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature.
    Bone Marrow Transplant. 2017;52:726-732.
    >> Share

    January 2017
  741. HAVERKOS BM, Huang Y, Elder P, O'Donnell L, et al
    A single center's experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    >> Share

    February 2016
  742. MASOURIDI-LEVRAT S, Simonetta F, Beauverd Y, Tsopra O, et al
    Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016